Profiles

Andrew Palmer

Professor Andrew Palmer

Andrew Palmer

New Star Professor of Medical Research, Founding Chair, Health Economics Research Unit
Menzies Institute for Medical Research

Room 353b-02 (Level 3), Medical Science 2, Hobart CBD Campuses

+61 3 6226 7729 (phone)

Andrew.Palmer@utas.edu.au

Prof Andrew Palmer is a New Star Professor of Medical Research and the Head of the Health Economics Research Unit at Menzies, working in the field of health economics since 1994. He is a leader in the subject of health economics in chronic diseases, has conducted research and published extensively in many disease areas including aged care/dementia, diabetes, multiple sclerosis, kidney disease, hypertension, dyslipidaemia, osteoporosis, alcoholism, growth hormone deficiency, rheumatoid arthritis, cardiovascular disease and oncology.

As well as being the Associate Editor (Health Economics) of Diabetic Medicine, he is the 2013-15 International Diabetes Federation (IDF) Chairman of the Task Force on Health Economics, the Co-founder/current Steering Committee member of the Mount Hood Modelling Diabetes Group, a Member of the 2013-15 Heart Foundation Future Fellows Selection Committee, member of the 2013-15 National Diabetes Strategy Group reporting to the Federal Minister for Health, Member of the Diabetes Australia Health Economics Expert Reference Group, and was an American Diabetes Association panel member for the development of diabetes health economics modelling guidelines.

Biography

Prof Palmer studied medicine at the University of Tasmania, after which he worked at the Launceston General Hospital, then as a general practitioner in Sydney. In 1994 he moved to Switzerland, where he was researcher and Medical Director of the Institute for Medical Informatics and Biostatistics (IMIB) from 1994 until 2000. CI Palmer co-founded CORE, Center for Outcomes Research, in Basel, Switzerland in July 2000 and was Medical Director and CEO until 2005. He was named by the International Society for Pharmacoeconomics and Outcomes Research as one of the top 10 most influential people in health economics in 2005.

Career summary

Qualifications

BmedSci, University of Tasmania, Australia, 1984
MBBS, University of Tasmania, Australia, 1987

Languages (other than English)

German (fluent written and oral)

Memberships

Professional practice

International Diabetes Federation (IDF) Chairman of the Task Force on Health Economics, 2013-15
National Diabetes Strategy Group reporting to the Federal Minister for Health, 2014-15

Committee associations

Heart Foundation Future Fellows Selection Committee, 2013-2015

Administrative expertise

Founding chair and head of the Department of Health Economics, Menzies Institute for Medical Research, University of Tasmania
Co-founder and current Steering Committee member of the Mount Hood Modelling Diabetes Group, the world's leading international diabetes health economics development and validation group

Teaching

Decision analysis, Modelling, Health economics, Diabetes, TreeAge software

Teaching expertise

Introduction to health economics
Practical methods in health economics
TreeAge Decision Analysis Software

Research Appointments

Member of the 2013, 2014, 2015 Heart Foundation Future Fellows Selection Committee
Member of the 2013-15 National Diabetes Strategy Group reporting to the Federal Minister for Health
Member of the Diabetes Australia Health Economics Expert Reference Group
Chairman, International Diabetes Federation, Task Force on Health Economics

View more on Professor Andrew Palmer in WARP

Expertise

Bicycle accident research
Horse racing industry health economics
Diabetes health economics
Workplace health promotion health economics
Haemochromatosis health economics
Multiple sclerosis health economics
Obesity health economics
Bariatric surgery health economics
Osteoporosis health economics
Aged care health economics

Research Themes

Professor Palmer's research aligns with the university's research theme of Better Health. He has conducted research and published extensively in the area of health economics and the modelling of diabetes and diabetes prevention.

In addition to his work in the area of diabetes, CI Palmer has conducted research and published extensively in other disease areas including multiple sclerosis, nephropathy and renal failure, hypertension, dyslipidaemia, deep vein thrombosis and pulmonary embolism prevention, osteoporosis, alcoholism, growth hormone deficiency, rheumatoid arthritis, cardiovascular disease and oncology.

CI Palmer led the development of the CORE Diabetes Model, which has been used to inform reimbursement and policy decisions regarding diabetes interventions on an international scale. The CORE Diabetes Model is the most widely published diabetes health economics model, and has been used in over 30 reimbursement submissions for pharmaceutical agents and devices worldwide. The methodology applied by CI Palmer's team has been used as the basis for international recommendations for guidelines in diabetes modelling.

CI Palmer co-founded, has chaired and been an active member of the Steering Committee of the Mount Hood Modelling Group, committed to the increased accuracy, validity and usefulness of complex diabetes models throughout the world. He was part of the American Diabetes Association Panel for developing guidelines/recommendations on the development of models of diabetes. The data generated from the MS prevalence and cost of illness study was used by Australia's leading MS advocacy group, MS Research Australia, to lobby the federal government for implementation of the Disability Insurance Scheme (in the meantime this has been passed with bipartisan support in the Federal Parliament).

Awards

ISPOR Asia-Pacific 2014 Best Research Poster Presentation
International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Asia-Pacific 2010: Best Research Podium Presentation
ISPOR Asia-Pacific 2010: Best Research Podium Presentation
Named by International Society for Pharmacoeconomics and Outcomes Research (ISPOR) as 'one of the 10 most influential people in the field of health economics and outcomes research in 2005'
ISPOR Europe 2005: Best Contributed Podium Presentation (first author)
ISPOR Europe 2004: Best Contributed Podium Presentation (co-author)
Deutsche Medizinische Wochenschrift (German Medical Journal) Walter Siegenthaler Preis 2001 (DMW Journal Article of the Year, 2001)

Current projects

Bariatric surgery in Tasmania: investigating health service use, costs, patient outcomes and policy options
Development of new diabetes health outcomes model
Development of new osteoporosis health outcomes model
Diabetes - Cost effectiveness of the COACH program in Tasmania, in association with Diabetes Tasmania
Diabetes - Mount Hood Challenge Conference Series
Haemochromatosis in Australia: a Cost of Illness Study
Health Economics of Haemochromatosis
Multiple Sclerosis - Development of an Australian Gold Standard Health Economics Model in conjunction with MS Research Australia
Tasmanian Cycling Habits Accident Risk and Costs

Fields of Research

Health Economics (140208)
Public Health and Health Services (111799)
Epidemiology (111706)
Central Nervous System (110903)
Aged Health Care (111702)
Cardiology (incl. Cardiovascular Diseases) (110201)
Neurology and Neuromuscular Diseases (110904)
Health and Community Services (111708)
Residential Client Care (111718)
Rheumatology and Arthritis (110322)
Health Promotion (111712)
Primary Health Care (111717)
Health Care Administration (111709)
Medical and Health Sciences (119999)
Paediatrics (111403)
Clinical Sciences (110399)
Complementary and Alternative Medicine (110499)
Endocrinology (110306)
Nephrology and Urology (110312)
Cardiorespiratory Medicine and Haematology (110299)
Health Information Systems (incl. Surveillance) (111711)
Aged Care Nursing (111001)
Surgery (110323)
Respiratory Diseases (110203)
Autonomic Nervous System (110901)
Gastroenterology and Hepatology (110307)
Health, Clinical and Counselling Psychology (170106)
Infectious Diseases (110309)
Aboriginal and Torres Strait Islander Health (111701)
Geriatrics and Gerontology (110308)
Psychiatry (incl. Psychotherapy) (110319)
Mental Health (111714)
Sociology (160899)
Applied Sociology, Program Evaluation and Social Impact Assessment (160801)
Environmental and Occupational Health and Safety (111705)
Sports Medicine (110604)
Preventive Medicine (111716)
Haematology (110202)
Medicine, Nursing and Health Curriculum and Pedagogy (130209)
Nursing (111099)
Architectural Science and Technology (incl. Acoustics, Lighting, Structure and Ecologically Sustainable Design) (120104)
Rehabilitation and Therapy (excl. Physiotherapy) (110321)
Educational Technology and Computing (130306)
Emergency Medicine (110305)
Allergy (110701)
Clinical Nursing: Primary (Preventative) (111002)
Peripheral Nervous System (110905)
Clinical Pharmacy and Pharmacy Practice (111503)
Health Policy (160508)

Research Objectives

Health Policy Economic Outcomes (920207)
Evaluation of Health Outcomes (920204)
Nervous System and Disorders (920111)
Public Health (excl. Specific Population Health) (920499)
Health Policy Evaluation (920208)
Injury Control (920409)
Diabetes (920104)
Respiratory System and Diseases (incl. Asthma) (920115)
Health Education and Promotion (920205)
Cardiovascular System and Diseases (920103)
Health and Support Services (920299)
Blood Disorders (920101)
Specific Population Health (excl. Indigenous Health) (920599)
Health Related to Ageing (920502)
Skeletal System and Disorders (incl. Arthritis) (920116)
Behaviour and Health (920401)
Preventive Medicine (920412)
Health (929999)
Mental Health (920410)
Health Status (e.g. Indicators of Well-Being) (920408)
Nursing (920210)
Infectious Diseases (920109)
Urogenital System and Disorders (920119)
Surgical Methods and Procedures (920118)
Cancer and Related Disorders (920102)
Neurodegenerative Disorders Related to Ageing (920112)
Clinical Health (Organs, Diseases and Abnormal Conditions) (920199)
Occupational Health (920505)
Allied Health Therapies (excl. Mental Health Services) (920201)
Digestive System Disorders (920105)
Disease Distribution and Transmission (incl. Surveillance and Response) (920404)
Aboriginal and Torres Strait Islander Health - Health System Performance (incl. Effectiveness of Interventions) (920303)
Substance Abuse (920414)
Aboriginal and Torres Strait Islander Health - Health Status and Outcomes (920302)
Carer Health (920202)
Disability and Functional Capacity (920403)
Education and Training Systems Policies and Development (930501)
Ageing and Older People (940103)
Road Safety (880109)
Residential Construction Design (870204)
Fixed Line Telephone Networks and Services (890102)
Rural Health (920506)
Immune System and Allergy (920108)
Palliative Care (920211)

Publications

Prof Palmer has an H-Index of 25 (Scopus January 31, 2014), over 100 PubMed-listed publications; 1,916 citations; article with highest number of citations=174; 19 articles cited more than 30 times.

He has been a reviewer for a number of major international journals and societies, including American Journal of Kidney Disease, Annals of Internal Medicine, Clinical Therapeutics, Current Medical Research and Opinion, Diabetes Care, Diabetes Obesity and Metabolism, Diabetic Medicine, Diabetologia, European Journal of Health Economics, Expert Opinions in Pharmacology, International Society for Pharmacoeconomics and Outcomes Research, Journal of the American Medical Association (JAMA), PharmacoEconomics, Swiss Medical Weekly and Value in Health. He has participated in numerous advisory boards and been a key member of several major medical and health economics workshops.

Total publications

188

Journal Article

(166 outputs)

Year	Citation	Altmetrics
2019	Campbell JA, Hensher M, Davies D, Green M, Hagan B, et al., 'Long-term inpatient hospital utilisation and costs (2007-08 to 2015-16) for publicly waitlisted bariatric surgery patients in an Australian public hospital system based on Australia's Activity Based Funding model', PharmacoEconomics - Open ISSN 2509-4254 (In Press) [Refereed Article] [eCite] [Details] Co-authors: Campbell JA; Venn A; Kuzminov A; Neil A
2019	Campbell JA, Simpson JR Steve, Ahmad H, Taylor BV, van der Mei I, et al., 'Change in multiple sclerosis prevalence over time in Australia 2010-2017 utilising disease modifying therapy prescription data', Multiple Sclerosis Journal ISSN 1352-4585 (In Press) [Refereed Article] [eCite] [Details] Co-authors: Campbell JA; Simpson JR Steve; Ahmad H; Taylor BV; van der Mei I Tweet
2019	Cocker F, Yee KC, Palmer AJ, de Graaff B, 'Increasing incidence and mortality related to liver cancer in Australia: time to turn the tide', Australian and New Zealand Journal of Public Health pp. 1-7. ISSN 1753-6405 (2019) [Refereed Article] DOI: 10.1111/1753-6405.12889 [eCite] [Details] Co-authors: Cocker F; Yee KC; de Graaff B Tweet
2019	Kuzminov A, Wilkinson S, Palmer AJ, Otahal P, Hensher M, et al., 'Rates and reasons for emergency department presentations of patients wait-listed for public bariatric surgery in Tasmania, Australia', Obesity Research and Clinical Practice, 13, (2) pp. 184-190. ISSN 1871-403X (2019) [Refereed Article] DOI: 10.1016/j.orcp.2019.01.002 [eCite] [Details] Co-authors: Kuzminov A; Otahal P; Hensher M; Venn AJ Tweet
2019	Lartey ST, Magnussen CG, Si L, de Graaff B, Biritwum RB, et al., 'The role of intergenerational educational mobility and household wealth in adult obesity: evidence from wave 2 of the World Health Organization's study on global ageing and adult health', PLoS ONE, 14, (1) Article e0208491. ISSN 1932-6203 (2019) [Refereed Article] DOI: 10.1371/journal.pone.0208491 [eCite] [Details] Co-authors: Lartey ST; Magnussen CG; Si L; de Graaff B Tweet
2019	Lartey ST, Si L, de Graaff B, Magnussen CG, Ahmad H, et al., 'Evaluation of the association between health state utilities and obesity in sub-Saharan Africa: Evidence from WHO Study on Global AGEing and Adult Health Wave 2', Value in Health ISSN 1098-3015 (In Press) [Refereed Article] [eCite] [Details] Co-authors: Lartey ST; Si L; de Graaff B; Magnussen CG; Ahmad H; Campbell J
2019	Palmer AJ, van der Mei I, Taylor BV, Clarke PM, Simpson Jr S, et al., 'Modelling the impact of multiple sclerosis on life expectancy, quality-adjusted life years and total lifetime costs: Evidence from Australia', Multiple Sclerosis Journal pp. 1-10. ISSN 1352-4585 (2019) [Refereed Article] DOI: 10.1177/1352458519831213 [eCite] [Details] Citations: Scopus - 1 Co-authors: van der Mei I; Taylor BV; Simpson Jr S; Ahmad H Tweet
2019	Tran-Duy A, McDermott R, Knight J, Hua X, Barr ELM, et al., 'Development and use of prediction models for classification of cardiovascular risk of remote indigenous Australians', Heart Lung and Circulation pp. 1-10. ISSN 1443-9506 (2019) [Refereed Article] DOI: 10.1016/j.hlc.2019.02.005 [eCite] [Details] Tweet
2019	Wang Z, Zhou X, Gao Y, Chen M, Palmer AJ, et al., 'Did expansion of health insurance coverage reduce horizontal inequity in healthcare finance? A decomposition analysis for China', BMJ Open, 9, (1) Article e025184. ISSN 2044-6055 (2019) [Refereed Article] DOI: 10.1136/bmjopen-2018-025184 [eCite] [Details] Tweet
2019	Canty D, Barth J, Yang Y, Peters N, Palmer A, et al., 'Comparison of learning outcomes for teaching focused cardiac ultrasound to physicians: A supervised human model course versus an eLearning guided self- directed simulator course', Journal of Critical Care, 49 pp. 38-44. ISSN 0883-9441 (2019) [Refereed Article] DOI: 10.1016/j.jcrc.2018.10.006 [eCite] [Details] Tweet
2018	Campbell JA, Ezzy D, Neil A, Hensher M, Venn A, et al., 'A qualitative investigation of the health economic impacts of bariatric surgery for obesity and implications for improved practice in health economics', Health Economics, 27, (8) pp. 1300-1318. ISSN 1057-9230 (2018) [Refereed Article] DOI: 10.1002/hec.3776 [eCite] [Details] Citations: Web of Science - 8 Co-authors: Campbell JA; Ezzy D; Neil A; Venn A; Sharman MJ Tweet
2018	Campbell JA, Hensher M, Neil A, Venn A, Otahal P, et al., 'An exploratory study: a head-to-head comparison of the EQ5D-5L and AQoL-8D for long-term publicly waitlisted bariatric surgery patients before and 3 months after bariatric surgery', PharmacoEconomics - Open, 2, (4) pp. 443-458. ISSN 2509-4254 (2018) [Refereed Article] DOI: 10.1007/s41669-017-0060-1 [eCite] [Details] Citations: Web of Science - 1 Co-authors: Campbell JA; Neil A; Venn A; Otahal P Tweet
2018	Canty DJ, Heiberg J, Yang Y, Royse AG, Margale S, et al., 'Pilot multi-centre randomised trial of the impact of pre-operative focused cardiac ultrasound on mortality and morbidity in patients having surgery for femoral neck fractures (ECHONOF-2 pilot)', Anaesthesia, 73, (4) pp. 428-437. ISSN 0003-2409 (2018) [Refereed Article] DOI: 10.1111/anae.14130 [eCite] [Details] Citations: Scopus - 7Web of Science - 7 Tweet
2018	Chen J, Taylor B, Palmer AJ, Kirk-Brown A, van Dijk P, et al., 'Estimating MS-related work productivity loss and factors associated with work productivity loss in a representative Australian sample of people with multiple sclerosis', Multiple Sclerosis Journal, (June) pp. 1-11. ISSN 1352-4585 (2018) [Refereed Article] DOI: 10.1177/1352458518781971 [eCite] [Details] Citations: Scopus - 1Web of Science - 2 Co-authors: Taylor B; Simpson Jr S; Blizzard L; van der Mei I Tweet
2018	Chen J, Taylor BV, Blizzard L, Simpson Jr S, Palmer AJ, et al., 'Effects of multiple sclerosis disease-modifying therapies on employment measures using patient-reported data', Journal of Neurology, Neurosurgery and Psychiatry, 89, (11) pp. 1200-1207. ISSN 0022-3050 (2018) [Refereed Article] DOI: 10.1136/jnnp-2018-318228 [eCite] [Details] Citations: Web of Science - 1 Co-authors: Taylor BV; Blizzard L; Simpson Jr S; van der Mei IAF Tweet
2018	Kilpatrick M, Nelson M, Palmer A, Jose K, Venn A, 'Who discusses reaching a healthy weight with a general practitioner? Findings from the 2014-2015 Australian National Health Survey', Obesity Research and Clinical Practice, 12, (5) pp. 459-464. ISSN 1871-403X (2018) [Refereed Article] DOI: 10.1016/j.orcp.2018.07.003 [eCite] [Details] Co-authors: Kilpatrick M; Nelson M; Jose K; Venn A Tweet
2018	Palmer AJ, Si L, Tew M, Hua X, Willis MS, et al., 'Computer modeling of diabetes and its transparency: a report on the Eighth Mount Hood Challenge', Value in Health, 21, (6) pp. 724-731. ISSN 1098-3015 (2018) [Refereed Article] DOI: 10.1016/j.jval.2018.02.002 [eCite] [Details] Citations: Scopus - 3Web of Science - 2 Co-authors: Si L Tweet
2018	Wang L, Cocker F, Kilpatrick M, Otahal P, Si L, et al., 'The associations of multimorbidity with health-related productivity loss in a large and diverse public sector setting: A cross-sectional survey', Journal of Occupational and Environmental Medicine, 60, (6) pp. 528-535. ISSN 1076-2752 (2018) [Refereed Article] DOI: 10.1097/JOM.0000000000001243 [eCite] [Details] Co-authors: Wang L; Cocker F; Kilpatrick M; Otahal P; Si L; Sanderson K Tweet
2018	Wang L, Si L, Cocker F, Palmer AJ, Sanderson K, 'A systematic review of cost-of-illness studies of multimorbidity', Applied Health Economics and Health Policy, 16, (1) pp. 15-29. ISSN 1175-5652 (2018) [Refereed Article] DOI: 10.1007/s40258-017-0346-6 [eCite] [Details] Citations: Scopus - 4Web of Science - 5 Co-authors: Wang L; Si L; Cocker F; Sanderson K Tweet
2018	de Graaff B, Yee KC, Clarke P, Palmer A, 'Uptake of and expenditure on direct-acting antiviral agents for Hepatitis C treatment in Australia', Applied Health Economics and Health Policy pp. 1-8. ISSN 1175-5652 (2018) [Refereed Article] DOI: 10.1007/s40258-018-0392-8 [eCite] [Details] Citations: Scopus - 1Web of Science - 2 Co-authors: de Graaff B; Yee KC Tweet
2018	Ahmad H, van der Mei I, Taylor BV, Lucas RM, Ponsonby A-L, et al., 'Estimation of annual probabilities of changing disability levels in Australians with relapsing-remitting multiple sclerosis', Multiple Sclerosis Journal pp. 1-9. ISSN 1352-4585 (2018) [Refereed Article] DOI: 10.1177/1352458518806103 [eCite] [Details] Citations: Scopus - 1 Co-authors: Ahmad H; van der Mei I; Taylor BV; Simpson S Tweet
2018	Campbell JA, Hensher M, Neil A, Venn A, Wilkinson S, et al., 'An exploratory study of long-term publicly waitlisted bariatric surgery patients' quality of life before and 1 year after bariatric surgery, and considerations for healthcare planners', PharmacoEconomics Open, 2, (1) pp. 63-76. ISSN 2509-4254 (2018) [Refereed Article] DOI: 10.1007/s41669-017-0038-z [eCite] [Details] Citations: Web of Science - 2 Co-authors: Campbell JA; Neil A; Venn A Tweet
2017	Wang L, Palmer AJ, Otahal P, Cocker F, Sanderson K, 'Multimorbidity and Health Care Service Utilization in the Australian Workforce', Journal of Occupational and Environmental Medicine, 59, (8) pp. 795-802. ISSN 1076-2752 (2017) [Refereed Article] DOI: 10.1097/JOM.0000000000001089 [eCite] [Details] Co-authors: Wang L; Otahal P; Cocker F; Sanderson K Tweet
2017	Chen M, Palmer AJ, Si L, 'Improving equity in health care financing in China during the progression towards Universal Health Coverage', BMC Health Services Research, 17, (1) Article 852. ISSN 1472-6963 (2017) [Refereed Article] DOI: 10.1186/s12913-017-2798-7 [eCite] [Details] Citations: Scopus - 1Web of Science - 1 Co-authors: Si L Tweet
2017	Sharman Melanie, Hensher M, Wilkinson S, Williams D, Palmer A, et al., 'What are the support experiences and needs of patients who have received bariatric surgery?', Health Expectations, 20, (1) pp. 35-46. ISSN 1369-6513 (2017) [Refereed Article] DOI: 10.1111/hex.12423 [eCite] [Details] Citations: Scopus - 7Web of Science - 4 Co-authors: Sharman Melanie; Williams D; Venn A; Ezzy D Tweet
2017	Si L, Chen M, Palmer AJ, 'Has equity in government subsidy on healthcare improved in China? Evidence from the China's National Health Services Survey', International Journal for Equity in Health, 16, (1) Article 6. ISSN 1475-9276 (2017) [Refereed Article] DOI: 10.1186/s12939-017-0516-z [eCite] [Details] Citations: Scopus - 3Web of Science - 2 Co-authors: Si L Tweet
2017	Si L, Shi L, Chen M, Palmer AJ, 'Establishing benchmark EQ-5D-3L population health state utilities and identifying their correlates in Gansu Province, China', Quality of Life Research, 26, (11) pp. 3049-3058. ISSN 0962-9343 (2017) [Refereed Article] DOI: 10.1007/s11136-017-1614-5 [eCite] [Details] Citations: Web of Science - 5 Co-authors: Si L Tweet
2017	Wang L, Palmer AJ, Cocker F, Sanderson K, 'Multimorbidity and health-related quality of life (HRQoL) in a nationally representative population sample: implications of count versus cluster method for defining multimorbidity on HRQoL', Health and Quality of Life Outcomes, 15, (1) Article 7. ISSN 1477-7525 (2017) [Refereed Article] DOI: 10.1186/s12955-016-0580-x [eCite] [Details] Citations: Scopus - 11Web of Science - 10 Co-authors: Wang L; Sanderson K Tweet
2017	Sharman MJ, Breslin MC, Kuzminov A, Palmer AJ, Blizzard L, et al., 'Population estimates and characteristics of Australians potentially eligible for bariatric surgery: findings from the 2011-13 Australian Health Survey', Australian Health Review pp. 1-9. ISSN 0156-5788 (2017) [Refereed Article] DOI: 10.1071/AH16255 [eCite] [Details] Citations: Scopus - 2Web of Science - 2 Co-authors: Sharman MJ; Breslin MC; Kuzminov A; Blizzard L; Hensher M; Venn AJ Tweet
2017	de Graaff B, Neil A, Sanderson K, Yee KC, Palmer AJ, 'Costs associated with hereditary haemochromatosis in Australia: a cost-of-illness study', Australian Health Review, 41, (3) pp. 254-267. ISSN 0156-5788 (2017) [Refereed Article] DOI: 10.1071/AH15188 [eCite] [Details] Citations: Scopus - 2Web of Science - 3 Co-authors: de Graaff B; Neil A; Sanderson K; Yee KC Tweet
2017	de Graaff B, Neil A, Si L, Yee KC, Sanderson K, et al., 'Cost-effectiveness of different population screening strategies for hereditary haemochromatosis in Australia', Applied Health Economics and Health Policy, 15, (4) pp. 521-534. ISSN 1175-5652 (2017) [Refereed Article] DOI: 10.1007/s40258-016-0297-3 [eCite] [Details] Citations: Scopus - 3Web of Science - 3 Co-authors: de Graaff B; Neil A; Si L; Yee KC; Sanderson K Tweet
2017	de Graaff B, Si L, Neil AL, Yee KC, Sanderson K, et al., 'Population Screening for Hereditary Haemochromatosis in Australia: Construction and Validation of a State-Transition Cost-Effectiveness Model', PharmacoEconomics - Open, 1, (1) pp. 37-51. ISSN 2509-4254 (2017) [Refereed Article] DOI: 10.1007/s41669-016-0005-0 [eCite] [Details] Citations: Scopus - 3Web of Science - 3 Co-authors: de Graaff B; Si L; Neil AL; Yee KC; Sanderson K Tweet
2017	Ahmad H, Taylor BV, van der Mei I, Colman S, O'Leary BA, et al., 'The impact of multiple sclerosis severity on health state utility values: Evidence from Australia', Multiple Sclerosis Journal, 23, (8) pp. 1157-1166. ISSN 1352-4585 (2017) [Refereed Article] DOI: 10.1177/1352458516672014 [eCite] [Details] Citations: Scopus - 6Web of Science - 5 Co-authors: Ahmad H; Taylor BV; van der Mei I; Breslin M Tweet
2017	Hua X, Lung TWC, Palmer A, Si L, Herman WH, et al., 'How consistent is the relationship between improved glucose control and modelled health outcomes for people with type 2 diabetes mellitus? a systematic review', PharmacoEconomics, 35, (3) pp. 319-329. ISSN 1170-7690 (2017) [Refereed Article] DOI: 10.1007/s40273-016-0466-0 [eCite] [Details] Citations: Scopus - 2Web of Science - 2 Co-authors: Si L Tweet
2016	Campbell JA, Palmer AJ, Venn A, Sharman M, Otahal P, et al., 'A head-to-head comparison of the EQ-5D-5L and AQoL-8D multi-attribute utility instruments in patients who have previously undergone bariatric surgery', The Patient, 9, (4) pp. 311-322. ISSN 1178-1653 (2016) [Refereed Article] DOI: 10.1007/s40271-015-0157-5 [eCite] [Details] Citations: Scopus - 6Web of Science - 10 Co-authors: Campbell JA; Venn A; Sharman M; Otahal P; Neil A Tweet
2016	Campbell JA, Venn A, Neil A, Hensher M, Sharman M, et al., 'Diverse approaches to the health economic evaluation of bariatric surgery: a comprehensive systematic review', Obesity Reviews, 17, (9) pp. 850-894. ISSN 1467-7881 (2016) [Refereed Article] DOI: 10.1111/obr.12424 [eCite] [Details] Citations: Scopus - 6Web of Science - 7 Co-authors: Campbell JA; Venn A; Neil A; Sharman M Tweet
2016	Chen M, Palmer AJ, Si L, 'Assessing equity in benefit distribution of government health subsidy in 2012 across East China: benefit incidence analysis', International Journal for Equity in Health, 15 Article 15. ISSN 1475-9276 (2016) [Refereed Article] DOI: 10.1186/s12939-016-0306-z [eCite] [Details] Citations: Scopus - 6Web of Science - 5 Co-authors: Si L Tweet
2016	Chen M, Si L, Winzenberg TM, Gu J, Jiang Q, et al., 'Cost-effectiveness of raloxifene in the treatment of osteoporosis in Chinese postmenopausal women: impact of medication persistence and adherence', Patient Preference and Adherence, 10 pp. 415-423. ISSN 1177-889X (2016) [Refereed Article] DOI: 10.2147/PPA.S100175 [eCite] [Details] Citations: Scopus - 1Web of Science - 1 Co-authors: Si L; Winzenberg TM Tweet
2016	Kuzminov A, Palmer AJ, Wilkinson S, Khatsiev B, Venn AJ, 'Re-operations after Secondary Bariatric Surgery: a Systematic Review', Obesity Surgery, 26, (9) pp. 2237-2247. ISSN 0960-8923 (2016) [Refereed Article] DOI: 10.1007/s11695-016-2252-7 [eCite] [Details] Citations: Scopus - 10Web of Science - 10 Co-authors: Kuzminov A; Venn AJ Tweet
2016	Neil AL, Nelson M, Palmer AJ, 'The new Australian after-hours general practice incentive payment mechanism: equity for rural general practice?', Health Policy, 120, (7) pp. 809-817. ISSN 0168-8510 (2016) [Refereed Article] DOI: 10.1016/j.healthpol.2016.05.005 [eCite] [Details] Co-authors: Neil AL; Nelson M Tweet
2016	Petrie D, Lung TW, Rawshani A, Palmer AJ, Svensson AM, et al., 'Recent trends in life expectancy for people with type 1 diabetes in Sweden', Diabetologia, 59, (6) pp. 1167-1176. ISSN 0012-186X (2016) [Refereed Article] DOI: 10.1007/s00125-016-3914-7 [eCite] [Details] Citations: Scopus - 28Web of Science - 26 Tweet
2016	Sharman MJ, Venn AJ, Hensher M, Wilkinson S, Palmer AJ, et al., 'Motivations for Seeking Bariatric Surgery: The Importance of Health Professionals and Social Networks', Bariatric Surgical Practice and Patient Care, 11, (3) pp. 104-109. ISSN 2168-023X (2016) [Refereed Article] DOI: 10.1089/bari.2016.0004 [eCite] [Details] Citations: Scopus - 3Web of Science - 3 Co-authors: Sharman MJ; Venn AJ; Williams D; Ezzy D Tweet
2016	Sharman MJ, Venn AJ, Jose KA, Williams D, Hensher M, et al., 'The support needs of patients waiting for publicly funded bariatric surgery - implications for health service planners', Clinical Obesity, 7, (1) pp. 46-53. ISSN 1758-8103 (2016) [Refereed Article] DOI: 10.1111/cob.12169 [eCite] [Details] Citations: Web of Science - 4 Co-authors: Sharman MJ; Venn AJ; Jose KA; Williams D; Ezzy D Tweet
2016	Annear MJ, Tierney LT, Vickers JC, Palmer AJ, 'Counting the cost of dementia-related hospital admissions: a regional investigation', Australasian Journal on Ageing, 35, (3) pp. E32-E35. ISSN 1440-6381 (2016) [Refereed Article] DOI: 10.1111/ajag.12318 [eCite] [Details] Citations: Scopus - 5Web of Science - 5 Co-authors: Annear MJ; Tierney LT; Vickers JC Tweet
2016	de Graaff B, Neil A, Sanderson K, Yee KC, Palmer AJ, 'Quality of life utility values for hereditary haemochromatosis in Australia', Health and Quality of Life Outcomes, 14, (1) Article 31. ISSN 1477-7525 (2016) [Refereed Article] DOI: 10.1186/s12955-016-0431-9 [eCite] [Details] Citations: Scopus - 6Web of Science - 7 Co-authors: de Graaff B; Neil A; Sanderson K; Yee KC Tweet
2016	Si L, Winzenberg TM, Chen M, Jiang Q, Neil A, et al., 'Screening for osteoporosis in Chinese post-menopausal women: a health economic modelling study', Osteoporosis International, 27, (7) pp. 2259-2269. ISSN 0937-941X (2016) [Refereed Article] DOI: 10.1007/s00198-016-3502-1 [eCite] [Details] Citations: Scopus - 4Web of Science - 3 Co-authors: Si L; Winzenberg TM; Neil A Tweet
2015	Baxter S, Campbell S, Sanderson K, Cazaly C, Venn A, et al., 'Development of the Workplace Health Savings Calculator: a practical tool to measure economic impact from reduced absenteeism and staff turnover in workplace health promotion', BMC Research Notes, 8 Article 457. ISSN 1756-0500 (2015) [Refereed Article] DOI: 10.1186/s13104-015-1402-7 [eCite] [Details] Citations: Scopus - 4 Co-authors: Baxter S; Sanderson K; Venn A Tweet
2015	Curry BA, Hitchens PL, Otahal P, Si L, Palmer AJ, 'Workplace injuries in thoroughbred racing: An analysis of insurance payments and injuries amongst jockeys in Australia from 2002 to 2010', Animals, 5, (3) pp. 897-909. ISSN 2076-2615 (2015) [Refereed Article] DOI: 10.3390/ani5030390 [eCite] [Details] Citations: Scopus - 5Web of Science - 4 Co-authors: Curry BA; Hitchens PL; Otahal P; Si L Tweet
2015	Curry BA, Hitchens PL, Otahal P, Si L, Palmer AJ, 'Australian insurance costs of jockeys injured in a race-day fall', Occupational Medicine, 66, (3) pp. 222-229. ISSN 1471-8405 (2015) [Refereed Article] DOI: 10.1093/occmed/kqv150 [eCite] [Details] Citations: Scopus - 2Web of Science - 2 Co-authors: Curry BA; Hitchens PL; Otahal P; Si L Tweet
2015	Hitchens PL, Curry B, Blizzard CL, Palmer AJ, 'A decision tree model for the implementation of a safety strategy in the horse-racing industry', Injury Prevention, 21, (2) pp. 109-114. ISSN 1475-5785 (2015) [Refereed Article] DOI: 10.1136/injuryprev-2014-041223 [eCite] [Details] Citations: Scopus - 3Web of Science - 3 Co-authors: Hitchens PL; Curry B; Blizzard CL Tweet
2015	Neil AL, Nelson MR, Richardson T, Mann-Leonard M, Palmer AJ, 'General practice after-hours incentive funding: a rationale for change', Medical Journal of Australia, 203, (2) pp. 82-85. ISSN 0025-729X (2015) [Refereed Article] DOI: 10.5694/mja14.01229 [eCite] [Details] Citations: Scopus - 3 Co-authors: Neil AL; Nelson MR Tweet
2015	Palmer AJ, Si L, Gordon JM, Saul T, Otahal P, et al., 'Investigating the costs of major and minor cycling crashes in Tasmania, Australia', Australian and New Zealand Journal of Public Health, 39, (5) pp. 485-490. ISSN 1753-6405 (2015) [Refereed Article] DOI: 10.1111/1753-6405.12384 [eCite] [Details] Co-authors: Si L; Gordon JM; Saul T; Otahal P; Hitchens PL Tweet
2015	Si L, Winzenberg TM, Chen M, Jiang Q, Palmer AJ, 'Residual lifetime and 10 year absolute risks of osteoporotic fractures in Chinese men and women', Current Medical Research and Opinion, 31, (6) pp. 1149-1156. ISSN 0300-7995 (2015) [Refereed Article] DOI: 10.1185/03007995.2015.1037729 [eCite] [Details] Citations: Scopus - 11Web of Science - 11 Co-authors: Si L; Winzenberg TM Tweet
2015	Si L, Winzenberg TM, Jiang Q, Chen M, Palmer AJ, 'Projection of osteoporosis-related fractures and costs in China: 2010-2050', Osteoporosis International, 26, (7) pp. 1929-1937. ISSN 0937-941X (2015) [Refereed Article] DOI: 10.1007/s00198-015-3093-2 [eCite] [Details] Citations: Scopus - 42Web of Science - 38 Co-authors: Si L; Winzenberg TM Tweet
2015	Si L, Winzenberg TM, Jiang Q, Palmer AJ, 'Screening for and treatment of osteoporosis: construction and validation of a state-transition microsimulation cost-effectiveness model', Osteoporosis International, 26, (5) pp. 1477-1489. ISSN 0937-941X (2015) [Refereed Article] DOI: 10.1007/s00198-014-2999-4 [eCite] [Details] Citations: Scopus - 8Web of Science - 7 Co-authors: Si L; Winzenberg TM Tweet
2015	de Graaff B, Neil A, Sanderson K, Si L, Yee KC, et al., 'A systematic review and narrative synthesis of health economic studies conducted for hereditary haemochromatosis', Applied Health Economics and Health Policy, 13, (5) pp. 469-483. ISSN 1175-5652 (2015) [Refereed Article] DOI: 10.1007/s40258-015-0189-y [eCite] [Details] Citations: Scopus - 5Web of Science - 4 Co-authors: de Graaff B; Neil A; Sanderson K; Si L; Yee KC Tweet
2015	Baxter S, Sanderson K, Venn A, Otahal P, Palmer AJ, 'Construct validity of SF-6D health state utility values in an employed population', Quality of Life Research, 24, (4) pp. 851-870. ISSN 1573-2649 (2015) [Refereed Article] DOI: 10.1007/s11136-014-0823-4 [eCite] [Details] Citations: Scopus - 3Web of Science - 4 Co-authors: Baxter S; Sanderson K; Venn A; Otahal P Tweet
2014	Cocker F, Nicholson JM, Graves N, Oldenburg B, Palmer AJ, et al., 'Depression in working adults: comparing the costs and health outcomes of working when ill', PLoS One, 9, (9) Article e105430. ISSN 1932-6203 (2014) [Refereed Article] DOI: 10.1371/journal.pone.0105430 [eCite] [Details] Citations: Scopus - 8Web of Science - 7 Co-authors: Cocker F; Martin A; Scott J; Venn A; Sanderson K Tweet
2014	Lung TWC, Hayes AJ, Herman WH, Si L, Palmer AJ, et al., 'A meta-analysis of the relative risk of mortality for type 1 diabetes patients compared to the general population: exploring temporal changes in relative mortality', PL o S One, 9, (11) Article e113635. ISSN 1932-6203 (2014) [Refereed Article] DOI: 10.1371/journal.pone.0113635 [eCite] [Details] Citations: Scopus - 8Web of Science - 8 Co-authors: Si L Tweet
2014	Elliott K-E, Annear MJ, Bell EJ, Palmer AJ, Robinson AL, 'Residents with mild cognitive decline and family members report health students 'enhance capacity of care' and bring 'a new breath of life' in two aged care facilities in Tasmania', Health Expectations pp. 1-14. ISSN 1369-6513 (2014) [Refereed Article] DOI: 10.1111/hex.12236 [eCite] [Details] Citations: Scopus - 7Web of Science - 7 Co-authors: Elliott K-E; Annear MJ; Bell EJ; Robinson AL Tweet
2014	Liebl A, Seitz L, Palmer AJ, 'Health economics analysis of insulin aspart vs. regular human insulin in Type 2 Diabetes patients, based on observational real life evidence from general practices in Germany', Experimental and Clinical Endocrinology & Diabetes, 122, (9) pp. 517-522. ISSN 0947-7349 (2014) [Refereed Article] DOI: 10.1055/s-0034-1376987 [eCite] [Details] Citations: Scopus - 1Web of Science - 1 Tweet
2014	Baxter S, Sanderson K, Venn AJ, Blizzard CL, Palmer AJ, 'The relationship between return on investment and quality of study methodology in workplace health promotion programs', American Journal of Health Promotion, 28, (6) pp. 347-363. ISSN 0890-1171 (2014) [Refereed Article] DOI: 10.4278/ajhp.130731-LIT-395 [eCite] [Details] Citations: Scopus - 69Web of Science - 61 Co-authors: Baxter S; Sanderson K; Venn AJ; Blizzard CL Tweet
2014	Lung TWC, Petrie D, Herman WH, Palmer AJ, Svensson AM, et al., 'Severe hypoglycemia and mortality after cardiovascular events for Type 1 diabetic patients in Sweden', Diabetes Care, 37, (11) pp. 2974-2981. ISSN 0149-5992 (2014) [Refereed Article] DOI: 10.2337/dc14-0405 [eCite] [Details] Citations: Scopus - 29Web of Science - 24 Tweet
2014	Palmer AJ, Si L, Gordon JM, Saul T, Curry BA, et al., 'Accident rates amongst regular bicycle riders in Tasmania, Australia', Accident Analysis and Prevention, 72 pp. 376-381. ISSN 0001-4575 (2014) [Refereed Article] DOI: 10.1016/j.aap.2014.07.015 [eCite] [Details] Citations: Scopus - 4Web of Science - 6 Co-authors: Si L; Gordon JM; Saul T; Curry BA; Otahal P; Hitchens PL Tweet
2014	Si L, Winzenberg TM, Palmer AJ, 'A systematic review of models used in cost-effectiveness analyses of preventing osteoporotic fractures', Osteoporosis International, 25, (1) pp. 51-60. ISSN 0937-941X (2014) [Refereed Article] DOI: 10.1007/s00198-013-2551-y [eCite] [Details] Citations: Scopus - 26Web of Science - 21 Co-authors: Si L; Winzenberg TM Tweet
2014	Si L, Winzenberg TM, de Graaff B, Palmer AJ, 'A systematic review and meta-analysis of utility-based quality of life for osteoporosis-related conditions', Osteoporosis International, 25, (8) pp. 1987-1997. ISSN 0937-941X (2014) [Refereed Article] DOI: 10.1007/s00198-014-2636-2 [eCite] [Details] Citations: Scopus - 34Web of Science - 29 Co-authors: Si L; Winzenberg TM; de Graaff B Tweet
2014	De Smit E, Palmer AJ, Hewitt AW, 'Projected worldwide disease burden from giant cell arteritis by 2050', Journal of Rheumatology, 42, (1) pp. 119-125. ISSN 1499-2752 (2014) [Refereed Article] DOI: 10.3899/jrheum.140318 [eCite] [Details] Citations: Scopus - 31Web of Science - 32 Co-authors: Hewitt AW Tweet
2013	McKercher CM, Venn AJ, Blizzard L, Nelson MR, Palmer AJ, et al., 'Psychosocial factors in adults with chronic kidney disease: characteristics of pilot participants in the Tasmanian Chronic Kidney Disease study', BMCNephrology, 14 Article 83. ISSN 1471-2369 (2013) [Refereed Article] DOI: 10.1186/1471-2369-14-83 [eCite] [Details] Citations: Scopus - 14Web of Science - 14 Co-authors: McKercher CM; Venn AJ; Blizzard L; Nelson MR; Ashby MA; Scott JL; Jose MD Tweet
2013	Palmer AJ, Colman S, O'Leary B, Taylor BV, Simmons RD, 'The economic impact of multiple sclerosis in Australia in 2010', Multiple Sclerosis, 19, (12) pp. 1640-1646. ISSN 1352-4585 (2013) [Refereed Article] DOI: 10.1177/1352458513488230 [eCite] [Details] Citations: Scopus - 30Web of Science - 27 Co-authors: Taylor BV Tweet
2013	Palmer AJ, Hitchens PL, Simpson Jr S, O'Leary B, Colman S, et al., 'A novel method for calculating prevalence of multiple sclerosis in Australia', Multiple Sclerosis, 19, (13) pp. 1704-1711. ISSN 1352-4585 (2013) [Refereed Article] DOI: 10.1177/1352458513479841 [eCite] [Details] Citations: Scopus - 9Web of Science - 8 Co-authors: Hitchens PL; Simpson Jr S; Taylor BV Tweet
2013	Taylor BV, Palmer A, Simpson Jr S, Lucas R, Simmons RD, et al., 'Assessing possible selection bias in a national voluntary MS longitudinal study in Australia', Multiple Sclerosis, 19, (12) pp. 1627-1631. ISSN 1352-4585 (2013) [Refereed Article] DOI: 10.1177/1352458513481511 [eCite] [Details] Citations: Scopus - 15Web of Science - 16 Co-authors: Taylor BV; Simpson Jr S Tweet
2013	Palmer AJ, 'Computer modeling of diabetes and its complications: a report on the fifth Mount Hood challenge meeting', Value in Health, 16, (4) pp. 670-685. ISSN 1098-3015 (2013) [Refereed Article] DOI: 10.1016/j.jval.2013.01.002 [eCite] [Details] Citations: Scopus - 69Web of Science - 55 Tweet
2012	Cooper MS, Palmer AJ, Seibel MJ, 'Cost-effectiveness of the Concord Minimal Trauma Fracture Liaison service, a prospective, controlled fracture prevention study', Osteoporosis International, 23, (1) pp. 97-107. ISSN 1433-2965 (2012) [Refereed Article] DOI: 10.1007/s00198-011-1802-z [eCite] [Details] Citations: Scopus - 58Web of Science - 52 Tweet
2012	Hitchens PL, Palmer AJ, 'Characteristics of, and insurance payments for, injuries to cyclists in Tasmania, 1990-2010', Accident Analysis & Prevention, 49 pp. 449-456. ISSN 0001-4575 (2012) [Refereed Article] DOI: 10.1016/j.aap.2012.03.013 [eCite] [Details] Citations: Scopus - 5Web of Science - 4 Co-authors: Hitchens PL Tweet
2012	Palmer AJ, Tucker DMD, 'Cost and clinical implications of diabetes prevention in an Australian setting: A long-term modeling analysis', Primary Care Diabetes, 6, (2) pp. 109-121. ISSN 1751-9918 (2012) [Refereed Article] DOI: 10.1016/j.pcd.2011.10.006 [eCite] [Details] Citations: Scopus - 23Web of Science - 23 Co-authors: Tucker DMD Tweet
2011	Valentine WJ, Palmer AJ, Lammert M, Langer J, Brandle M, 'Evaluating the Long-Term Cost-Effectiveness of Liraglutide Versus Exenatide BID in Patients With Type 2 Diabetes Who Fail to Improve With Oral Antidiabetic Agents', Clinical Therapeutics: The International, Peer-Reviewed Journal of Drug Therapy, 33, (11) pp. 1698-1712. ISSN 0149-2918 (2011) [Refereed Article] DOI: 10.1016/j.clinthera.2011.09.022 [eCite] [Details] Citations: Scopus - 16Web of Science - 13 Tweet
2009	Valentine WJ, Tucker D, Palmer AJ, Minshall ME, Foos V, et al., 'Long-Term Cost-Effectiveness of Pioglitazone versus Placebo in Addition to Existing Diabetes Treatment: A US Analysis Based on PROactive', Value in Health, 12, (1) pp. 1-9. ISSN 1098-3015 (2009) [Refereed Article] DOI: 10.1111/j.1524-4733.2008.00403.x [eCite] [Details] Citations: Scopus - 9Web of Science - 10 Tweet
2008	Chirakup S, Chaiyakunapruk N, Chaikledkeaw U, Pongcharoensuk P, Ongphiphadhanakul B, et al., 'Cost-effectiveness analysis of thiazolidinediones in uncontrolled type 2 diabetic patients receiving sulfonylureas and metformin in Thailand', Value in Health, 11, (Supplement 1) pp. S43-S51. ISSN 1098-3015 (2008) [Refereed Article] DOI: 10.1111/j.1524-4733.2008.00366.x [eCite] [Details] Citations: Scopus - 14Web of Science - 10 Tweet
2008	Gaede P, Valentine WJ, Palmer AJ, Tucker DMD, Lammert M, et al., 'Cost-effectiveness of Intensified versus conventional multifactorial intervention in type 2 diabetes: Results and projections from the Steno-2 study', Diabetes Care, 31, (8) pp. 1510-1515. ISSN 0149-5992 (2008) [Refereed Article] DOI: 10.2337/dc07-2452 [eCite] [Details] Citations: Scopus - 102Web of Science - 90 Tweet
2008	Goodall G, Jendle JH, Valentine WJ, Munro V, Brandt AB, et al., 'Biphasic insulin aspart 70/30 vs. insulin glargine in insulin naive type 2 diabetes patients: modelling the long-term health economic implications in a Swedish setting', International Journal of Clinical Practice, 62, (6) pp. 869-876. ISSN 1368-5031 (2008) [Refereed Article] DOI: 10.1111/j.1742-1241.2008.01766.x [eCite] [Details] Citations: Scopus - 13Web of Science - 9 Tweet
2008	Minshall ME, Oglesby AK, Wintle ME, Valentine WJ, Roze S, et al., 'Estimating the long-term cost-effectiveness of exenatide in the United States: an adjunctive treatment for type 2 diabetes mellitus', Value in Health, 11, (1) pp. 22-33. ISSN 1098-3015 (2008) [Refereed Article] DOI: 10.1111/j.1524-4733.2007.00211.x [eCite] [Details] Citations: Scopus - 29Web of Science - 27 Tweet
2008	Palmer AJ, Lammert M, Hermansen K, 'Health economic consequences of insulin analogues in the treatment of type 1 diabetes in Denmark', Ugeskrift for Laeger , 170, (15) pp. 1250-1254. ISSN 1603-6824 (2008) [Refereed Article] PMID: 18433583 [eCite] [Details] Citations: Scopus - 8 Tweet
2008	Palmer AJ, Valentine WJ, Chen R, Mehin N, Gabriel S, et al., 'A health economic analysis of screening and optimal treatment of nephropathy in patients with type 2 diabetes and hypertension in the USA', Nephrology, Dialysis and Transplantation, 23, (4) pp. 1216-1223. ISSN 0931-0509 (2008) [Refereed Article] DOI: 10.1093/ndt/gfn082 [eCite] [Details] Citations: Scopus - 50Web of Science - 48 Tweet
2008	Palmer JL, Goodall G, Nielsen S, Kotchie RW, Valentine WJ, et al., 'Cost-effectiveness of insulin aspart versus human soluble insulin in type 2 diabetes in four European countries: subgroup analyses from the PREDICTIVE study', Current Medical Research and Opinion, 24, (5) pp. 1417-1428 . ISSN 0300-7995 (2008) [Refereed Article] DOI: 10.1185/030079908X297295 [eCite] [Details] Citations: Scopus - 13Web of Science - 8 Tweet
2008	Ray JA, Borker R, Barber B, Valentine WJ, Belozeroff V, et al., 'Cost-Effectiveness of Early versus Late Cinacalcet Treatment in Addition to Standard Care for Secondary Renal Hyperparathyroidism in the USA', Value in Health, 11, (5) pp. 800-808. ISSN 1098-3015 (2008) [Refereed Article] DOI: 10.1111/j.1524-4733.2008.00329.x [eCite] [Details] Citations: Scopus - 13Web of Science - 12 Tweet
2008	Valentine WJ, Goodall G, Aagren M, Nielsen S, Palmer AJ, et al., 'Evaluating the cost-effectiveness of therapy conversion to insulin detemir in patients with type 2 diabetes in Germany: a modelling study of long-term clinical and cost outcomes', Advances in Therapy: The International Journal of Drug, Device and Diagnostic Research, 25, (6) pp. 567-584. ISSN 0741-238X (2008) [Refereed Article] DOI: 10.1007/s12325-008-0069-z [eCite] [Details] Citations: Scopus - 22Web of Science - 14 Tweet
2007	Alberti KGMM, Zimmet P, Shaw J, Unwin N, Orchard T, et al., 'International Diabetes Federation: a consensus on Type 2 diabetes prevention', Diabetic Medicine, 24, (5) pp. 451-463. ISSN 0742-3071 (2007) [Refereed Article] DOI: 10.1111/j.1464-5491.2007.02157.x [eCite] [Details] Citations: Scopus - 416Web of Science - 362 Tweet
2007	Annemans L, Demarteau N, Hu SL, Lee TJ, Morad Z, et al., 'An Asian Regional Analysis of Cost-Effectiveness of Early Irbesartan Treatment versus Conventional Antihypertensive, Late Amlodipine, and Late Irbesartan Treatments in Patients with Type 2 Diabetes, Hypertension, and Nephropathy', Value in Health, 11, (3) pp. 354-364. ISSN 1098-3015 (2007) [Refereed Article] DOI: 10.1111/j.1524-4733.2007.00250.x [eCite] [Details] Citations: Scopus - 12Web of Science - 12 Tweet
2007	Coyle D, Rodby R, Soroka S, Levin A, Muirhead N, et al., 'Cost-effectiveness of irbesartan 300 mg given early versus late in patients with hypertension and a history of type 2 diabetes and renal disease: a Canadian perspective', Clinical Therapeutics: The International, Peer-Reviewed Journal of Drug Therapy, 29, (7) pp. 1508-1523. ISSN 0149-2918 (2007) [Refereed Article] DOI: 10.1016/j.clinthera.2007.07.029 [eCite] [Details] Citations: Scopus - 12Web of Science - 11 Tweet
2007	Erny-Albrecht K, Valentine WJ, Christensen J, Vestenbaek U, Palmer AJ, 'Sublingual Immunotherapy in Allergic Rhinitis and Asthma: A Review of Recent Clinical Evidence', Journal of Applied Research: in Clinical and Experimental Therapeutics, 7, (1) pp. 17-31. ISSN 1537-064X (2007) [Refereed Article] [eCite] [Details]
2007	Gilmer TP, Roze S, Valentine WJ, Emy-Albrecht K, Ray JA, et al., 'Cost-effectiveness of diabetes case management for low-income populations', Health Services Research, 42, (5) pp. 1943-1959. ISSN 0017-9124 (2007) [Refereed Article] DOI: 10.1111/j.1475-6773.2007.00701.x [eCite] [Details] Citations: Scopus - 49Web of Science - 45 Tweet
2007	Palmer AJ, Roze S, Valentine WJ, McEwan P, Gillett M, et al., 'Computer modeling of diabetes and its complications - A report on the Fourth Mount Hood Challenge Meeting', Diabetes Care, 30, (6) pp. 1638-1646. ISSN 0149-5992 (2007) [Refereed Article] DOI: 10.2337/dc07-9919 [eCite] [Details] Citations: Scopus - 164Web of Science - 124 Tweet
2007	Palmer AJ, Valentine WJ, Ray JA, 'Irbesartan treatment of patients with type 2 diabetes, hypertension and renal disease: a UK health economics analysis', International Journal of Clinical Practice, 61, (10) pp. 1626-1633. ISSN 1368-5031 (2007) [Refereed Article] DOI: 10.1111/j.1742-1241.2007.01343.x [eCite] [Details] Citations: Scopus - 6Web of Science - 6 Tweet
2007	Palmer AJ, Valentine WJ, Ray JA, Foos V, Lurati F, et al., 'An economic assessment of analogue basal-bolus insulin versus human basal-bolus insulin in subjects with type 1 diabetes in the UK', Current Medical Research and Opinion, 23, (4) pp. 895-901. ISSN 0300-7995 (2007) [Refereed Article] DOI: 10.1185/030079907X182194 [eCite] [Details] Citations: Scopus - 26Web of Science - 21 Tweet
2007	Palmer AJ, Valentine WJ, Ray JA, Roze S, Muszbek N, 'Health economic implications of irbesartan treatment versus standard blood pressure control in patients with type 2 diabetes, hypertension and renal disease: a Hungarian analysis', The European Journal of Health Economics, 8, (2) pp. 161-168. ISSN 1618-7598 (2007) [Refereed Article] DOI: 10.1007/s10198-006-0033-2 [eCite] [Details] Citations: Scopus - 7Web of Science - 7 Tweet
2007	Ray JA, Boye KS, Yurgin N, Valentine WJ, Roze S, et al., 'Exenatide versus insulin glargine in patients with type 2 diabetes in the UK: a model of long-term clinical and cost outcomes', Current Medical Research and Opinion, 23, (3) pp. 609-622. ISSN 0300-7995 (2007) [Refereed Article] DOI: 10.1185/030079907X178685 [eCite] [Details] Citations: Scopus - 48Web of Science - 36 Tweet
2007	Ray JA, Valentine WJ, Palmer AJ, 'Cost-utility analysis of cinacalcet in addition to standard of care in the UK', Nephrology, Dialysis and Transplantation, 22, (11) pp. 3355-3357. ISSN 0931-0509 (2007) [Refereed Article] DOI: 10.1093/ndt/gfm434 [eCite] [Details] Citations: Scopus - 4Web of Science - 4 Tweet
2007	Ray JA, Valentine WJ, Roze S, Nicklasson L, Cobden D, et al., 'Insulin therapy in type 2 diabetes patients failing oral agents: cost-effectiveness of biphasic insulin aspart 70/30 vs. insulin glargine in the US', Diabetes Obesity & Metabolism, 9, (1) pp. 103-113. ISSN 1462-8902 (2007) [Refereed Article] DOI: 10.1111/j.1463-1326.2006.00581.x [eCite] [Details] Citations: Scopus - 28Web of Science - 22 Tweet
2007	Valentine WJ, Bottomley JM, Palmer AJ, Brandle M, Foos V, et al., 'PROactive 06: cost-effectiveness of pioglitazone in Type 2 diabetes in the UK', Diabetic Medicine, 24, (9) pp. 982-1002. ISSN 0742-3071 (2007) [Refereed Article] DOI: 10.1111/j.1464-5491.2007.02188.x [eCite] [Details] Citations: Scopus - 27Web of Science - 25 Tweet
2007	Valentine WJ, Erny-Albrecht KM, Ray JA, Roze S, Cobden D, et al., 'Therapy conversion to insulin detemir among patients with type 2 diabetes treated with oral agents: a modeling study of cost-effectiveness in the United States', Advances in Therapy: The International Journal of Drug, Device and Diagnostic Research, 24, (2) pp. 273-290. ISSN 0741-238X (2007) [Refereed Article] DOI: 10.1007/BF02849895 [eCite] [Details] Citations: Scopus - 22Web of Science - 14 Tweet
2007	Cohen N, Minshall ME, Sharon-Nash L, Zakrzewska K, Valentine WJ, et al., 'Continuous Subcutaneous Insulin Infusion versus Multiple Daily Injections of Insulin: Economic Comparison in Adult and Adolescent Type 1 Diabetes Mellitus in Australia', Pharmacoeconomics, 25, (10) pp. 881-897. ISSN 1170-7690 (2007) [Refereed Article] DOI: 10.2165/00019053-200725100-00006 [eCite] [Details] Citations: Scopus - 37Web of Science - 24 Tweet
2006	Valentine WJ, Palmer AJ, Nicklasson L, Cobden D, Roze S, 'Improving life expectancy and decreasing the incidence of complications associated with type 2 diabetes: a modelling study of HbA1c targets', International Journal of Clinical Practice, 60, (9) pp. 1138-1145. ISSN 1368-5031 (2006) [Refereed Article] DOI: 10.1111/j.1742-1241.2006.01102.x [eCite] [Details] Citations: Scopus - 28Web of Science - 23 Tweet
2006	Currie CJ, McEwan P, Poole C, Valentine WJ, Palmer AJ, et al., 'Comments on Long-term clinical and cost outcomes of treatment with biphasic insulin aspart 30/70 versus insulin glargine in insulin-naive type 2 diabetes patients: cost-effectiveness analysis in the UK setting', Current Medical Research and Opinion, 22, (5) pp. 967-969. ISSN 0300-7995 (2006) [Letter or Note in Journal] DOI: 10.1185/030079906X00000 [eCite] [Details] Citations: Web of Science - 2 Tweet
2006	Palmer AJ, Currie CJ, 'Modelling lifetime metabolic progression and cost effectiveness of treatment strategies for type 2 diabetes', Pharmacoeconomics, 24, (9) pp. 927-929. ISSN 1170-7690 (2006) [Contribution to Refereed Journal] DOI: 10.2165/00019053-200624090-00009 [eCite] [Details] Citations: Scopus - 2Web of Science - 2 Tweet
2006	Palmer AJ, Dinneen S, Gavin JR, Gray A, Herman WH, et al., 'Cost-utility analysis in a UK setting of self-monitoring of blood glucose in patients with type 2 diabetes', Current Medical Research and Opinion, 22, (5) pp. 861-872. ISSN 0300-7995 (2006) [Refereed Article] DOI: 10.1185/030079906X104669 [eCite] [Details] Citations: Scopus - 42Web of Science - 31 Tweet
2006	Bottomley J, Palmer AJ, Williams R, Dormandy J, Massi-Benedetti M, 'PROactive 03: Pioglitazone, type 2 diabetes and reducing macrovascular events - economic implications?', British Journal of Diabetes and Vascular Disease , 6, (2) pp. 63-70. ISSN 1474-6514 (2006) [Refereed Article] DOI: 10.1177/14746514060060020401 [eCite] [Details] Citations: Scopus - 7 Tweet
2006	Palmer AJ, Roze S, Valentine WJ, Ray JA, Frei A, et al., 'Health economic implications of irbesartan plus conventional antihypertensive medications versus conventional blood pressure control alone in patients with type 2 diabetes, hypertension, and renal disease in Switzerland', Swiss Medical Weekly, 136, (21-22) pp. 346-352. ISSN 1424-7860 (2006) [Refereed Article] PMID: 16779715 [eCite] [Details] Citations: Scopus - 6Web of Science - 5 Tweet
2006	Palmer AJ, Valentine WJ, Tucker DMD, Ray JA, Roze S, et al., 'A French cost-consequence analysis of the renoprotective benefits of irbesartan in patients with type 2 diabetes and hypertension', Current Medical Research and Opinion, 22, (11) pp. 2095-2100. ISSN 0300-7995 (2006) [Refereed Article] DOI: 10.1185/030079906X132730 [eCite] [Details] Citations: Scopus - 8Web of Science - 8 Tweet
2006	Roze S, Liens D, Palmer AJ, Berger W, Tucker D, et al., 'A health economic model to determine the long-term costs and clinical outcomes of raising low HDL-cholesterol in the prevention of coronary heart disease', Current Medical Research and Opinion, 22, (12) pp. 2549-2556. ISSN 0300-7995 (2006) [Refereed Article] DOI: 10.1185/030079906X148490 [eCite] [Details] Citations: Scopus - 5Web of Science - 4 Tweet
2006	Roze S, Valentine WJ, Evers T, Palmer AJ, 'Acarbose in addition to existing treatments in patients with type 2 diabetes: health economic analysis in a German setting', Current Medical Research and Opinion, 22, (7) pp. 1415-1424. ISSN 0300-7995 (2006) [Refereed Article] DOI: 10.1185/030079906X115531 [eCite] [Details] Citations: Scopus - 7Web of Science - 6 Tweet
2006	Roze S, Valentine WJ, Zakrzewska K, Palmer AJ, 'Cost-effectiveness of CSII - Response (Response to the letter by Philip Home)', Diabetic Medicine, 23, (6) pp. 707-708. ISSN 0742-3071 (2006) [Letter or Note in Journal] DOI: 10.1111/j.1464-5491.2006.1854_2.x [eCite] [Details] Tweet
2006	Tucker DMD, Palmer AJ, Valentine WJ, Roze S, Ray JA, 'Counting the costs of overweight and obesity: modeling clinical and cost outcomes', Current Medical Research and Opinion, 22, (3) pp. 575-586. ISSN 0300-7995 (2006) [Refereed Article] DOI: 10.1185/030079906X96227 [eCite] [Details] Citations: Scopus - 26Web of Science - 22 Tweet
2006	Valentine WJ, Palmer AJ, Erny-Albrecht KM, Ray JA, Cobden D, et al., 'Cost-effectiveness of basal insulin from a US health system perspective: Comparative analyses of detemir, glargine, and NPH', Advances in Therapy: The International Journal of Drug, Device and Diagnostic Research, 23, (2) pp. 191-207. ISSN 0741-238X (2006) [Refereed Article] DOI: 10.1007/BF02850126 [eCite] [Details] Citations: Scopus - 40Web of Science - 28 Tweet
2006	Palmer AJ, Chen R, Valentine WJ, Roze S, Bregman B, et al., 'Cost-consequence analysis in a French setting of screening and optimal treatment of nephropathy in hypertensive patients with type 2 diabetes', Diabetes & Metabolism, 32, (1) pp. 69-76. ISSN 1262-3636 (2006) [Refereed Article] DOI: 10.1016/S1262-3636(07)70249-5 [eCite] [Details] Citations: Scopus - 10Web of Science - 9 Tweet
2006	Palmer AJ, Roze S, Rodby RA, Valentine WJ, Ritz E, et al., 'Clinical and health economic implications of early treatment with irbesartan of patients with type 2 diabetes mellitus, hypertension and nephropathy', Deutsche Medizinische Wochenschrift, 131, (31-32) pp. 1721-1726. ISSN 0012-0472 (2006) [Refereed Article] DOI: 10.1055/s-2006-947822 [eCite] [Details] Citations: Scopus - 6Web of Science - 6 Tweet
2005	Minshall ME, Roze S, Palmer AJ, Valentine WJ, Foos V, et al., 'Treating diabetes to accepted standards of care: a 10-year projection of the estimated economic and health impact in patients with type 1 and type 2 diabetes mellitus in the United States', Clinical Therapeutics: The International, Peer-Reviewed Journal of Drug Therapy, 27, (6) pp. 940-950. ISSN 0149-2918 (2005) [Refereed Article] DOI: 10.1016/j.clinthera.2005.06.006 [eCite] [Details] Citations: Scopus - 30Web of Science - 26 Tweet
2005	Palmer AJ, Annemans L, Roze S, Lapuerta P, Chen R, et al., 'Irbesartan is projected to be cost and life saving in a Spanish setting for treatment of patients with type 2 diabetes, hypertension, and microalbuminuria', Kidney International, 67, (Supplement 93) pp. S52-S54 . ISSN 0085-2538 (2005) [Refereed Article] DOI: 10.1111/j.1523-1755.2005.09312.x [eCite] [Details] Citations: Scopus - 15Web of Science - 15 Tweet
2005	Palmer AJ, Tucker DMD, Ray JA, Valentine WJ, Currie C, et al., 'Insulin pumps: more consultation was needed', BMJ, 331, (7521) pp. 905-906. ISSN 0959-8146 (2005) [Letter or Note in Journal] DOI: 10.1136/bmj.331.7521.905-c [eCite] [Details] Citations: Web of Science - 1 Tweet
2005	Palmer AJ, Tucker DMD, Valentine WJ, Roze S, Gabriel S, et al., 'Cost-effectiveness of irbesartan in diabetic nephropathy: a systematic review of published studies', Nephrology, Dialysis and Transplantation, 20, (6) pp. 1103-1109. ISSN 0931-0509 (2005) [Refereed Article] DOI: 10.1093/ndt/gfh802 [eCite] [Details] Citations: Scopus - 18Web of Science - 13 Tweet
2005	Palmer AJ, 'Health economics--what the nephrologist should know', Nephrology, Dialysis and Transplantation, 20, (6) pp. 1038-1041. ISSN 0931-0509 (2005) [Contribution to Refereed Journal] [eCite] [Details]
2005	Poldrugo F, Haeger DA, Comte S, Walburg J, Palmer AJ, 'A critical review of pharmacoeconomic studies of acamprosate', Alcohol and Alcoholism, 40, (5) pp. 422-430. ISSN 0735-0414 (2005) [Refereed Article] DOI: 10.1093/alcalc/agh171 [eCite] [Details] Citations: Scopus - 13Web of Science - 11 Tweet
2005	Ray JA, Valentine WJ, Secnik K, Oglesby AK, Cordony A, et al., 'Review of the cost of diabetes complications in Australia, Canada, France, Germany, Italy and Spain', Current Medical Research and Opinion, 21, (10) pp. 1617-1629. ISSN 0300-7995 (2005) [Refereed Article] DOI: 10.1185/030079905X65349 [eCite] [Details] Citations: Scopus - 81Web of Science - 69 Tweet
2005	Roze S, Valentine WJ, Zakrzewska KE, Palmer AJ, 'Health-economic comparison of continuous subcutaneous insulin infusion with multiple daily injection for the treatment of Type 1 diabetes in the UK', Diabetic Medicine, 22, (9) pp. 1239-1245. ISSN 0742-3071 (2005) [Refereed Article] DOI: 10.1111/j.1464-5491.2005.01576.x [eCite] [Details] Citations: Scopus - 72Web of Science - 60 Tweet
2005	Valentine WJ, Palmer AJ, Lammert M, Nicklasson L, Foos V, et al., 'Long-term clinical and cost outcomes of treatment with biphasic insulin aspart 30/70 versus insulin glargine in insulin naive type 2 diabetes patients: cost-effectiveness analysis in the UK setting', Current Medical Research and Opinion, 21, (12) pp. 2063-2071. ISSN 0300-7995 (2005) [Refereed Article] DOI: 10.1185/030079905X74989 [eCite] [Details] Citations: Scopus - 30Web of Science - 24 Tweet
2005	Palmer AJ, Valentine WJ, Roze S, Lammert M, Spiesser J, et al., 'Overview of costs of stroke from published, incidence-based studies spanning 16 industrialized countries', Current Medical Research and Opinion, 21, (1) pp. 19-26. ISSN 0300-7995 (2005) [Refereed Article] DOI: 10.1185/030079904X17992 [eCite] [Details] Citations: Scopus - 32Web of Science - 32 Tweet
2004	Bergemann R, Brown J, Chan W, Clarke P, Eddy D, et al., 'Guidelines for computer modeling of diabetes and its complications', Diabetes Care, 27, (9) pp. 2262-2265. ISSN 0149-5992 (2004) [Refereed Article] [eCite] [Details] Citations: Web of Science - 95
2004	Palmer AJ, Annemans L, Roze S, Lamotte A, Rodby RA, et al., 'Cost-effectiveness of Ibersartan in type II diabetic nephropathy with hypertension. A Spanish perspective', Nefrologia, 24, (3) pp. 231-238. ISSN 0211-6995 (2004) [Refereed Article] [eCite] [Details] Citations: Web of Science - 14
2004	Palmer AJ, Annemans L, Roze S, Lamotte M, Lapuerta P, et al., 'Cost-Effectiveness of Early Irbesartan Treatment Versus Control (Standard Antihypertensive Medications Excluding ACE Inhibitors, Other Angiotensin-2 Receptor Antagonists, and Dihydropyridine Calcium Channel Blockers) or Late Irbesartan Treatment in Patients With Type 2 Diabetes, Hypertension, and Renal Disease', Diabetes Care, 27, (8) pp. 1897-1903. ISSN 0149-5992 (2004) [Refereed Article] DOI: 10.2337/diacare.27.8.1897 [eCite] [Details] Citations: Scopus - 70Web of Science - 65 Tweet
2004	Palmer AJ, Annemans L, Roze S, Lamotte M, Rodby RA, et al., 'An economic evaluation of the Irbesartan in Diabetic Nephropathy Trial (IDNT) in a UK setting', Journal of Human Hypertension, 18, (10) pp. 733-738. ISSN 0950-9240 (2004) [Refereed Article] DOI: 10.1038/sj.jhh.1001729 [eCite] [Details] Citations: Scopus - 29Web of Science - 25 Tweet
2004	Palmer AJ, Annemans L, Roze S, Lamotte M, Rodby RA, et al., 'Health economic consequences of irbesartan treatment of type 2 diabetes patients with nephropathy and hypertension in German', Deutsche Medizinische Wochenschrift, 129, (1-2) pp. 13-18. ISSN 0012-0472 (2004) [Refereed Article] DOI: 10.1055/s-2004-812656 [eCite] [Details] Citations: Scopus - 18Web of Science - 15 Tweet
2004	Palmer AJ, Rodby RA, 'Health economics studies assessing irbesartan use in patients with hypertension, type 2 diabetes, and microalbuminuria', Kidney International. Supplement , (92) pp. S118-S120. ISSN 0098-6577 (2004) [Refereed Article] [eCite] [Details]
2004	Palmer AJ, Roze S, Lammert M, Valentine WJ, Minshall ME, et al., 'Comparing the long-term cost-effectiveness of repaglinide plus metformin versus nateglinide plus metformin in type 2 diabetes patients with inadequate glycaemic control: an application of the CORE Diabetes Model in type 2 diabetes', Current Medical Research and Opinion, 20, (Supplement 1) pp. S41-S51. ISSN 0300-7995 (2004) [Refereed Article] DOI: 10.1185/030079904X2015 [eCite] [Details] Citations: Scopus - 15Web of Science - 16 Tweet
2004	Palmer AJ, Roze S, Valentine WJ, Minshall ME, Foos V, et al., 'The CORE Diabetes Model: Projecting long-term clinical outcomes, costs and cost-effectiveness of interventions in diabetes mellitus (types 1 and 2) to support clinical and reimbursement decision-making', Current Medical Research and Opinion, 20, (Supplement 1) pp. S5-S26. ISSN 0300-7995 (2004) [Refereed Article] DOI: 10.1185/030079904X1980 [eCite] [Details] Citations: Web of Science - 239 Tweet
2004	Palmer AJ, Roze S, Valentine WJ, Minshall ME, Foos V, et al., 'Validation of the CORE Diabetes Model against epidemiological and clinical studies', Current Medical Research and Opinion, 20, (Supplement 1) pp. S27-S40. ISSN 0300-7995 (2004) [Refereed Article] DOI: 10.1185/030079904X2006 [eCite] [Details] Citations: Scopus - 203Web of Science - 157 Tweet
2004	Palmer AJ, Roze S, Valentine WJ, Minshall ME, Hayes C, et al., 'Impact of changes in HbA1c, lipids and blood pressure on long-term outcomes in type 2 diabetes patients: an analysis using the CORE Diabetes Model', Current Medical Research and Opinion, 20, (1) pp. S53-S58. ISSN 0300-7995 (2004) [Refereed Article] DOI: 10.1185/030079903125002611 [eCite] [Details] Citations: Scopus - 33Web of Science - 26 Tweet
2004	Palmer AJ, Roze S, Valentine WJ, Minshall ME, Lammert M, et al., 'What impact would pancreatic beta-cell preservation have on life expectancy, quality-adjusted life expectancy and costs of complications in patients with type 2 diabetes? A projection using the CORE Diabetes Model', Current Medical Research and Opinion, 20, (1) pp. S59-S66. ISSN 0300-7995 (2004) [Refereed Article] DOI: 10.1185/030079904X2024 [eCite] [Details] Citations: Web of Science - 11 Tweet
2004	Palmer AJ, Roze S, Valentine WJ, Minshall ME, Lammert M, et al., 'Deleterious effects of increased body weight associated with intensive insulin therapy for type 1 diabetes: increased blood pressure and worsened lipid profile partially negate improvements in life expectancy', Current Medical Research and Opinion, 20, (Supplement 1) pp. S67-S73. ISSN 0300-7995 (2004) [Refereed Article] DOI: 10.1185/030079904X2033 [eCite] [Details] Citations: Web of Science - 12 Tweet
2004	Palmer AJ, Roze S, Valentine WJ, Smith I, Wittrup-Jensen KU, 'Cost-effectiveness of detemir-based basal/bolus therapy versus NPH-based basal/bolus therapy for type 1 diabetes in a UK setting: an economic analysis based on meta-analysis results of four clinical trials', Current Medical Research and Opinion, 20, (11) pp. 1729-1746 . ISSN 0300-7995 (2004) [Refereed Article] DOI: 10.1185/030079904X5661 [eCite] [Details] Citations: Scopus - 38Web of Science - 27 Tweet
2004	Palmer AJ, Roze S, Valentine WJ, Spinas G, 'The cost-effectiveness of continuous subcutaneous insulin infusion compared with multiple daily injections for the management of diabetes: response to Scuffham [corrected] and Carr', Diabetic Medicine, 21, (12) pp. 1372-1372. ISSN 0742-3071 (2004) [Letter or Note in Journal] DOI: 10.1111/j.1464-5491.2004.1349a.x [eCite] [Details] Citations: Web of Science - 3 Tweet
2004	Palmer AJ, Roze S, Valentine WJ, Spinas GA, Shaw JE, et al., 'Intensive lifestyle changes or metformin in patients with impaired glucose tolerance: modeling the long-term health economic implications of the diabetes prevention program in Australia, France, Germany, Switzerland, and the United Kingdom', Clinical Therapeutics: The International, Peer-Reviewed Journal of Drug Therapy, 26, (2) pp. 304-321. ISSN 0149-2918 (2004) [Refereed Article] DOI: 10.1016/S0149-2918(04)90029-X [eCite] [Details] Citations: Scopus - 96Web of Science - 79 Tweet
2003	Palmer AJ, Annemans L, Roze S, Lamotte M, Rodby RA, et al., 'An Economic Evaluation of Irbesartan in the Treatment of Patients with Type 2 Diabetes, Hypertension and Nephropathy: Cost-Effectiveness of Irbesartan in Diabetic Nephropathy Trial (IDNT) in the Belgian and French Settings', Nephrology, Dialysis and Transplantation, 18, (10) pp. 2059-2066. ISSN 0931-0509 (2003) [Refereed Article] DOI: 10.1093/ndt/gfg232 [eCite] [Details] Citations: Scopus - 42Web of Science - 36 Tweet
2003	Roze S, Palmer AJ, Valentine WJ, 'A multivariate logistic regression equation to screen for diabetes: response to Tabaei and Herman', Diabetes Care, 26, (5) pp. 1658-1659. ISSN 0149-5992 (2003) [Letter or Note in Journal] DOI: 10.2337/diacare.26.5.1658 [eCite] [Details] Citations: Scopus - 1Web of Science - 2 Tweet
2003	Rodby RA, Chiou CF, Borenstein J, Smitten A, Sengupta N, et al., 'The cost-effectiveness of irbesartan in the treatment of hypertensive patients with type 2 diabetic nephropathy', Clinical Therapeutics: The International, Peer-Reviewed Journal of Drug Therapy, 25, (7) pp. 2102-2119 . ISSN 0149-2918 (2003) [Refereed Article] DOI: 10.1016/S0149-2918(03)80208-4 [eCite] [Details] Citations: Scopus - 45Web of Science - 31 Tweet
2002	Coyle D, Palmer AJ, Tam R, 'Economic evaluation of pioglitazone hydrochloride in the management of type 2 diabetes mellitus in Canada', Pharmacoeconomics, 20, (Supplement 1) pp. 31-42. ISSN 1170-7690 (2002) [Refereed Article] DOI: 10.2165/00019053-200220001-00004 [eCite] [Details] Citations: Web of Science - 21 Tweet
2002	Sendi P, Palmer AJ, Hauri P, Craig BA, Horber FF, 'Modeling the impact of adjustable gastric banding on survival in patients with morbid obesity', Obesity Research, 10, (4) pp. 291-295. ISSN 1071-7323 (2002) [Refereed Article] DOI: 10.1038/oby.2002.40 [eCite] [Details] Citations: Scopus - 4Web of Science - 4 Tweet
2001	Gozzoli V, Palmer AJ, Brandt A, Spinas GA, 'Economic and clinical impact of alternative disease management strategies for secondary prevention in type 2 diabetes in the Swiss setting ', Swiss Medical Weekly, 131, (21-22) pp. 303-310. ISSN 1424-7860 (2001) [Refereed Article] [eCite] [Details] Citations: Web of Science - 18
2001	Gozzoli V, Palmer AJ, Brandt A, Weiss C, Piehlmeier W, et al., 'Increased clinical and economic advantage of proteinuric screening and intervention (PROSIT project) in type 2 diabetics', Deutsche Medizinische Wochenschrift, 125, (39) pp. 1154-1159. ISSN 0012-0472 (2001) [Refereed Article] DOI: 10.1055/s-2000-7670 [eCite] [Details] Citations: Scopus - 19Web of Science - 12 Tweet
2001	Palmer AJ, 'Commentary: Intensive glucose control is more costly than conventional treatment but also has more benefits for people with type-2 diabetes', Evidence - Based Healthcare and Public Health, 5, (1) pp. 17-18. ISSN 1744-2249 (2001) [Contribution to Refereed Journal] DOI: 10.1054/ebhc.2000.0376 [eCite] [Details] Tweet
2001	Palmer AJ, Sendi PP, 'New aspects in health economic studies of prevention and treatment of osteoporosis', Expert Review of Pharmacoeconomics & Outcomes Research, 1, (2) pp. 198-204. ISSN 1744-8379 (2001) [Refereed Article] DOI: 10.1586/14737167.1.2.198 [eCite] [Details] Tweet
2001	Sendi P, Palmer AJ, Gafni A, Battegay M, 'Highly Active Antiretroviral Therapy: Pharmacoeconomic issues in the management of HIV infection', Pharmacoeconomics, 19, (7) pp. 709-713. ISSN 1170-7690 (2001) [Refereed Article] DOI: 10.2165/00019053-200119070-00001 [eCite] [Details] Citations: Scopus - 29Web of Science - 24 Tweet
2000	Brown JB, Palmer AJ, Bisgaard P, Chan W, Pedula K, et al., 'The Mt. Hood Challenge: cross-testing two diabetes simulation models', Diabetes Research and Clinical Practice, 50, (Supplement 3) pp. S57-S64. ISSN 0168-8227 (2000) [Refereed Article] DOI: 10.1016/S0168-8227(00)00217-5 [eCite] [Details] Citations: Web of Science - 44 Tweet
2000	Palmer AJ, Brandt A, Gozzoli V, Weiss C, Stock H, et al., 'Outline of a diabetes disease management model: principles and applications', Diabetes Research and Clinical Practice, 50, (Supplement 3) pp. S47-S56. ISSN 0168-8227 (2000) [Refereed Article] DOI: 10.1016/S0168-8227(00)00216-3 [eCite] [Details] Citations: Web of Science - 24 Tweet
2000	Palmer AJ, Neeser K, Weiss C, Brandt A, Comte S, et al., 'The long-term cost-effectiveness of improving alcohol abstinence with adjuvant acamprosate', Alcohol and Alcoholism, 35, (5) pp. 478-492. ISSN 0735-0414 (2000) [Refereed Article] DOI: 10.1093/alcalc/35.5.478 [eCite] [Details] Citations: Web of Science - 33 Tweet
2000	Palmer AJ, Sendi PP, Spinas GA, 'Applying some UK Prospective Diabetes Study results to Switzerland: The cost-effectiveness of intensive glycemic control with metformin versus conventional control in overweight patients with type 2 diabetes', Schweizerische Medizinische Wochenschrift, 130, (27-28) pp. 1034-1040. ISSN 0036-7672 (2000) [Refereed Article] [eCite] [Details] Citations: Web of Science - 19
2000	Palmer AJ, Weiss C, Sendi PP, Neeser K, Brandt A, et al., 'The cost-effectiveness of different management strategies for type I diabetes: a Swiss perspective', Diabetologia: Clinical and Experimental Diabetes and Metabolism, 43, (1) pp. 13-26. ISSN 0012-186X (2000) [Refereed Article] DOI: 10.1007/s001250050003 [eCite] [Details] Citations: Scopus - 80Web of Science - 65 Tweet
2000	Sendi P, Palmer AJ, 'Modeling the socioeconomic impact of osteoporosis-related hip fractures in Switzerland', Osteoporosis International, 11, (1) pp. 92-94 . ISSN 0937-941X (2000) [Refereed Article] DOI: 10.1007/s001980050011 [eCite] [Details] Citations: Scopus - 6Web of Science - 6 Tweet
1999	Palmer AJ, Sendi PP, 'Meta-analysis in oral health care', Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics, 87, (2) pp. 135-141. ISSN 1079-2104 (1999) [Refereed Article] DOI: 10.1016/S1079-2104(99)70262-3 [eCite] [Details] Citations: Scopus - 8Web of Science - 7 Tweet
1999	Sendi PP, Palmer AJ, Marinello CP, 'Some principles of cost-effectiveness analysis in dentistry', Acta Medicinae Dentium Helvetica, 4, (4) pp. 63-67. ISSN 1420-8873 (1999) [Refereed Article] [eCite] [Details]
1998	Neeser K, Brandt A, Palmer AJ, Volz A, 'Gesundheitsoekonomische Auswirkungen der Algodystrophie unter Einbezug von Calcitonin [Health economic effects of calcitonin on algodystrophy]', Managed Care (Switzerland), 1, (6) pp. 39-43. ISSN 1422-6618 (1998) [Refereed Article] [eCite] [Details]
1998	Palmer AJ, Neeser K, Paschen B, Cleland JGF, 'Economic implications of the Total Ischemic Burden Bisoprolol Study (TIBBS) follow-up', Journal of Medical Economics , 1, (1-4) pp. 263-280. ISSN 1941-837X (1998) [Refereed Article] DOI: 10.3111/199801263280 [eCite] [Details] Citations: Scopus - 2 Tweet
1997	Kirchhof B, Palmer AJ, Kakkar VV, Bergemann R, 'The Economic Burden of Deep Vein Thrombosis Sequelae: A Cost of Illness Analysis for Germany', Gesundheitsoekonomie und Qualitaetsmanagement , 2 pp. 40-44. ISSN 1439-4049 (1997) [Refereed Article] [eCite] [Details]
1997	Palmer AJ, Brandt A, 'The cost-effectiveness of gemcitabine plus cisplatin chemotherapy versus mitomycin ifosfamide and cisplatin (MIP), etopiside plus cisplatin, and vinorelbine plus cisplatin in the treatment of stages III B and IV non-small cell lung cancer: An Italian perspective (letter)', Monaldi Archives for Chest Disease, 52, (3) pp. 305-306. ISSN 1122-0643 (1997) [Letter or Note in Journal] [eCite] [Details]
1997	Palmer AJ, Koppenhagen K, Kirchhof B, Weber U, Bergemann R, 'Efficacy and safety of low molecular weight heparin, unfractionated heparin and warfarin for thromboembolism prophylaxis in orthopaedic surgery: A meta-analysis of randomised clinical trials', Haemostasis, 27, (2) pp. 75-84. ISSN 0301-0147 (1997) [Refereed Article] [eCite] [Details] Citations: Web of Science - 73
1997	Palmer AJ, Schramm W, Kirchhof B, Bergemann R, 'Low Molecular Weight Heparin for Prevention of Thromboembolism in General Surgery: A Meta-Analysis of Randomized Clinical Trials with Low Molecular Weight Heparin, Unfractionated Heparin, and Warfarin', Haemostasis, 27, (2) pp. 65-74. ISSN 0301-0147 (1997) [Refereed Article] [eCite] [Details] Citations: Web of Science - 54
1997	Sendi PP, Palmer AJ, Marinello CP, 'Health State Utilities in Dentistry: A Review', Acta Medicinae Dentium Helvetica, 2, (10) pp. 243-248. ISSN 1420-8873 (1997) [Refereed Article] [eCite] [Details]
1996	Palmer AJ, Brandt A, 'The cost-effectiveness of gemcitabine plus cisplatin chemotherapy versus mitomycin ifosfamide and cisplatin (MIP), etopiside plus cisplatin, and vinorelbine plus cisplatin in the treatment of stages III B and IV non-small cell lung cancer: An Italian perspective', Monaldi Archives for Chest Disease, 51, (4) pp. 279-288. ISSN 1122-0643 (1996) [Refereed Article] [eCite] [Details]

Chapter in Book

(1 outputs)

Year	Citation	Altmetrics
2014	Si L, Palmer AJ, 'Prevention of T2DM: health economics', Diapedia. The living textbook of diabetes., R. Landgraf (ed) (2014) [Other Book Chapter] DOI: 10.14496/dia.0104770156.4 [eCite] [Details] Co-authors: Si L Tweet

Year

Citation

Altmetrics

2014

Si L, Palmer AJ, 'Prevention of T2DM: health economics', Diapedia. The living textbook of diabetes., R. Landgraf (ed) (2014) [Other Book Chapter]

DOI: 10.14496/dia.0104770156.4 [eCite] [Details]

Co-authors: Si L

Review

(2 outputs)

Year	Citation	Altmetrics
2012	Liebl A, Prusty V, Valensi P, Kawamori R, Christiansen JS, et al., 'Ten years of experience with biphasic insulin aspart 30: from drug development to the latest clinical findings', Drugs, 72, (11) pp. 1495-1520. ISSN 0012-6667 (2012) [Substantial Review] DOI: 10.2165/11635490-000000000-00000 [eCite] [Details] Citations: Scopus - 24Web of Science - 20 Tweet
2011	Tucker DMD, Palmer AJ, 'The cost-effectiveness of interventions in diabetes: A review of published economic evaluations in the UK setting, with an eye on the future', Primary Care Diabetes, 5, (1) pp. 9-17. (2011) [Substantial Review] DOI: 10.1016/j.pcd.2010.10.001 [eCite] [Details] Citations: Scopus - 6Web of Science - 5 Co-authors: Tucker DMD Tweet

Year

Citation

Altmetrics

2012

Liebl A, Prusty V, Valensi P, Kawamori R, Christiansen JS, et al., 'Ten years of experience with biphasic insulin aspart 30: from drug development to the latest clinical findings', Drugs, 72, (11) pp. 1495-1520. ISSN 0012-6667 (2012) [Substantial Review]

DOI: 10.2165/11635490-000000000-00000 [eCite] [Details]

Citations: Scopus - 24Web of Science - 20

2011

Tucker DMD, Palmer AJ, 'The cost-effectiveness of interventions in diabetes: A review of published economic evaluations in the UK setting, with an eye on the future', Primary Care Diabetes, 5, (1) pp. 9-17. (2011) [Substantial Review]

DOI: 10.1016/j.pcd.2010.10.001 [eCite] [Details]

Citations: Scopus - 6Web of Science - 5

Co-authors: Tucker DMD

Conference Publication

(12 outputs)

Year	Citation	Altmetrics
2018	Campbell JA, Ezzy D, Neil A, Hensher M, Venn A, et al., 'PCP4 A qualitative investigation of information asymmetry for obesity surgery: Diversity of patient experiences in the information age and demand-induced supply', Value in Health, pp. S23, Vol 21. ISSN 1098-3015 (2018) [Conference Extract] [eCite] [Details] Co-authors: Campbell JA; Ezzy D; Neil A; Venn A; Sharman M
2018	Lartey ST, Ahmad H, Si L, de Graaff B, Magnussen CG, et al., 'Health state utilities and high body mass index: evidence from WHO study of global ageing and adult health (SAGE)', Value in Health, pp. S109 (PSY20). (2018) [Conference Extract] [eCite] [Details] Co-authors: Lartey ST; Ahmad H; Si L; de Graaff B; Magnussen CG
2018	Campbell JA, Hensher M, Davies D, Green M, Hagan B, et al., 'PSY33 A Cost-Outcome Study: A real-world investigation of long-term inpatient hospital utilisation and costs for a retrospective cohort of bariatric surgery patients in an Australian public hospital system based on Australia's activity based funding model', Value in Health, pp. S111, Vol 21. ISSN 1098-3015 (2018) [Conference Extract] [eCite] [Details] Co-authors: Campbell JA; Venn A; Kuzminov A; Neil A
2016	Ahmad H, van der Mei I, Taylor B, Palmer AJ, 'PND13 - Assessing Health-State Utility Values in Australian People with Multiple Sclerosis', Value in Health, pp. A875, 19 (7). (2016) [Conference Extract] DOI: 10.1016/j.jval.2016.08.342 [eCite] [Details] Co-authors: Ahmad H; van der Mei I; Taylor B Tweet
2016	Campbell JA, Hensher M, Venn A, Neil A, Otahal P, et al., 'PSY15 A unique opportunity to assess quality-of-life changes in long-term waitlisted bariatric surgery patients using the EQ-5D-5L and AQOL-8D multi-attribute utility instruments before and three months after bariatric surgery: an exploratory study', Value in Health, pp. A882, Vol 19. ISSN 1098-3015 (2016) [Conference Extract] [eCite] [Details] Co-authors: Campbell JA; Venn A; Neil A; Otahal P
2016	Palmer AJ, Taylor B, Van der Mei I, Si L, Ahmad H, 'CU3 - Life Expectancy, Quality-Adjusted Life Years, and Total Lifetime Costs for Australian People with Multiple Sclerosis', Value in Health, pp. A808, 19 (7). (2016) [Conference Extract] DOI: 10.1016/j.jval.2016.08.722 [eCite] [Details] Co-authors: Taylor B; Van der Mei I; Si L; Ahmad H Tweet
2016	Walters H, Tierney L, Annear M, Elliott KJ, Palmer A, et al., 'Assessment and management of chronic respiratory conditions in frail older adults', Respirology, pp. 145, 21 (2). ISSN 1323-7799 (2016) [Conference Extract] DOI: 10.1111/resp.12755 [eCite] [Details] Co-authors: Walters H; Tierney L; Annear M; Elliott KJ; Robinson A Tweet
2016	de Graaff BL, Neil A, Sanderson K, Yee KC, Palmer AJ, 'PND9 - An Australian National Cost of Illness Study For Hereditary Haemochromatosis', Value in Health, pp. A874, 19 (7). ISSN 1098-3015 (2016) [Conference Extract] DOI: 10.1016/j.jval.2016.08.344 [eCite] [Details] Co-authors: de Graaff BL; Neil A; Sanderson K; Yee KC Tweet
2016	de Graaff BL, Si L, Neil A, Yee KC, Sanderson K, et al., 'PND10 - Cost-Effectiveness of Population Screening for Haemochromatosis In Australia: A State-Transition Model', Value in Health, pp. A874-A875, Vol 19 (7). ISSN 1098-3015 (2016) [Conference Extract] DOI: 10.1016/j.jval.2016.08.345 [eCite] [Details] Co-authors: de Graaff BL; Si L; Neil A; Yee KC; Sanderson K Tweet
2015	de Graaff BL, Neil A, Sanderson K, Yee KC, Palmer A, 'The impact of increasing severity of hereditary haemochromatosis on health state utility values', Value in Health, pp. A300, Vol 18, A1-A307. ISSN 1098-3015 (2015) [Conference Extract] [eCite] [Details] Co-authors: de Graaff BL; Neil A; Sanderson K; Yee KC
2014	McKercher C, Venn A, Blizzard CL, Nelson M, Palmer AJ, et al., 'Psychosocial factors in chronic kidney disease: 2 year follow-up of pilot participants', Nephrology, pp. 17-57, 19 (Supp 4). ISSN 1320-5358 (2014) [Conference Extract] [eCite] [Details] Co-authors: McKercher C; Venn A; Blizzard CL; Nelson M; Ashby M; Scott J; Jose MD
2013	Elliott K-E, Annear MJ, Bell EJ, Palmer AJ, Robinson AL, 'Dementia tsunami in aged care: can students improve residents' quality of life?', The 46th Australian Association of Gerontology National Conference, 27-29 Nov, Sydeny, NSW (2013) [Conference Extract] [eCite] [Details] Co-authors: Elliott K-E; Annear MJ; Bell EJ; Robinson AL

Contract Report, Consultant's Report

(4 outputs)

Year	Citation	Altmetrics
2018	Ahmad H, Campbell JA, van der Mei I, Taylor B, Palmer AJ, 'Health Economic Impact of Multiple Sclerosis in Australia in 2017: An analysis of MS Research Australia's platform - the Australian MS Longitudinal Study (AMSLS)', Multiple Sclerosis Research Australia (2018) [Contract Report] [eCite] [Details] Co-authors: Ahmad H; Campbell JA; van der Mei I; Taylor B
2016	Neil A, de Graaff B, Nelson M, Chappell K, Palmer A, et al., 'Tasmanian After-Hours Primary Care Service Innovations: A Report in Three Parts', Primary Health Tasmania (2016) [Contract Report] [eCite] [Details] Co-authors: Neil A; de Graaff B; Nelson M; Chappell K; Sanderson K
2014	Neil A, Nelson M, Palmer AJ, 'General Practice After Hours Practice Funding: 2014-15 Funding Model', Tasmania Medicare Local (2014) [Contract Report] [eCite] [Details] Co-authors: Neil A; Nelson M
2011	Palmer AJ, 'Economic Impact of Multiple Sclerosis in 2010: Australian MS Longitudinal Study', Multiple Sclerosis Research Australia (2011) [Consultants Report] [eCite] [Details]

Other Public Output

(3 outputs)

Year	Citation	Altmetrics
2019	Doherty B, Nash R, Elmer S, Campbell J, Julian R, et al., 'Lead Support Coordinator Service (LSCS) Evaluation Report', Prepared for the Department of Communities, Tasmania, Australia (2019) [Report of Restricted Access] [eCite] [Details] Co-authors: Doherty B; Nash R; Elmer S; Campbell J; Julian R; Vandenberg M; West S; de Graaff B
2016	Neil A, de Graaff B, Chappell K, Sanderson K, Palmer A, et al., 'What Value GP Assist? The comparative benefits of, and satisfaction with GP Assist in Residential Aged Care Facilities and General Practice in Rural and Urban Tasmania', Department of Health and Human Services, Tasmanian Government (2016) [Government or Industry Research] [eCite] [Details] Co-authors: Neil A; de Graaff B; Chappell K; Sanderson K; Nelson M
2015	Neil A, Nelson M, Sanderson K, Palmer A, 'Improving the availability and efficiency of appropriate urgent service provision in Tasmania: Interim evaluation of the GP Assist and the Tasmanian General Practice After-Hours Incentive Funding Model 2014-15', Tasmania Medicare Local (2015) [Government or Industry Research] [eCite] [Details] Co-authors: Neil A; Nelson M; Sanderson K

Year

Citation

Altmetrics

2019

Doherty B, Nash R, Elmer S, Campbell J, Julian R, et al., 'Lead Support Coordinator Service (LSCS) Evaluation Report', Prepared for the Department of Communities, Tasmania, Australia (2019) [Report of Restricted Access]

[eCite] [Details]

Co-authors: Doherty B; Nash R; Elmer S; Campbell J; Julian R; Vandenberg M; West S; de Graaff B

2016

Neil A, de Graaff B, Chappell K, Sanderson K, Palmer A, et al., 'What Value GP Assist? The comparative benefits of, and satisfaction with GP Assist in Residential Aged Care Facilities and General Practice in Rural and Urban Tasmania', Department of Health and Human Services, Tasmanian Government (2016) [Government or Industry Research]

[eCite] [Details]

Co-authors: Neil A; de Graaff B; Chappell K; Sanderson K; Nelson M

2015

Neil A, Nelson M, Sanderson K, Palmer A, 'Improving the availability and efficiency of appropriate urgent service provision in Tasmania: Interim evaluation of the GP Assist and the Tasmanian General Practice After-Hours Incentive Funding Model 2014-15', Tasmania Medicare Local (2015) [Government or Industry Research]

[eCite] [Details]

Co-authors: Neil A; Nelson M; Sanderson K

Grants & Funding

Funding Summary

Number of grants

Total funding

$10,601,590

Projects

Evaluation of the Tasmanian Elective Surgery Panel Project (2019)$9,980

Description: In 2015, the Tasmanian State Government allocated additional funds to reduce the public hospital elective surgery waiting lists. A subset of waitlisted patients was fast-tracked for elective surgery to hospitals in Tasmania and Victoria. This project will evaluate the outcomes of this initiative.
Funding: Royal Hobart Hospital Research Foundation ($9,980)
Scheme: Grant-Incubator
Administered By: University of Tasmania
Research Team: de Graaff B; Song J; Hensher M; Campbell JA; Glading JA; Palmer AJ
Year: 2019

What is the economic impact of allergic respiratory disease in Tasmania? (2019)$10,000

Description: This project will provide the first economic assessment of the burden of allergic respiratory disease (allergic rhinitis and allergic asthma) in Tasmania. Together, allergic rhinitis and allergic asthma affect over 20% of the Tasmanian population, yet there has been no rigorousanalysis of the health and economic impacts. This project will cost the direct and indirect costs of these conditions across Tasmania. In doing so, we will provide a rigorous evidence base to build a case for allergic respiratory research, and directly inform government and non-government investment in interventions. Our research will be co-designed with expert input from government and non-government stakeholders (Asthma Australia) to ensure alignment with end-user needs.
Funding: University of Tasmania ($10,000)
Scheme: Grant-Research Enhancement Program
Administered By: University of Tasmania
Research Team: Johnston F; Palmer AJ; Jones PJ; Bereznicki BJ; Cooling NB; Zosky GR
Year: 2019

The Royal Hobart Hospital's innovative Rapid Access Chest Pain Clinic (RACPC): A health economic evaluation of patient, RHH and community benefits (2019)$24,952

Description: The overall aim of this project is to conduct a comprehensive health economic evaluation of the RHHs cutting-edge Rapid Access Chest Pain Clinic (RACPC) patient care model, compared to the usual care General Cardiology (GCC) clinic model for RHH patients with newly presented chest pain. The RACPC commenced in June 2014 and has realised positive clinical outcomes for its patients. Our comprehensive health economic investigation will build on the clinical work to systematically evaluate the health economic benefits of this innovative models patient pathways for people who present to the RHHs Emergency Department (approximately 70%) or by referral from a primary care physician (approximately 30%) with new onset chest pain.
Funding: Royal Hobart Hospital Research Foundation ($24,952)
Scheme: Grant-Project
Administered By: University of Tasmania
Research Team: Campbell JA; Black Andrew; Palmer AJ; Sharman JE; Hensher M; de Graaff B
Year: 2019

Lead Support Coordinator Service (LSCS) Evaluation (2018)$99,999

Description: The LSCS trials a new model of coordinated care for clients with complex needs . Three community service organisations, Australian Red Cross, Mission Australia and Baptcare will employ 12 Lead service. Coordinators to provide the service to a maximum of 30 Tasmanians with multiple service needs. Clients will work with the coordinator to identify needs and match them to available services. The evaluation aims to test if this model of coordination leads to better health and wellbeing outcomes for the clients and more efficient and cost effective service delivery.
Funding: Department of Health and Human Services Tasmania ($99,999)
Scheme: Contract Research
Administered By: University of Tasmania
Research Team: Doherty BT; Nash RE; de Graaff B; Julian RD; Campbell JA; Palmer AJ
Year: 2018

NHMRC Panel for services relating to health evidence, advice and methods (2018)$10

Description: NHMRC wishes to establish a panel of providers with relevant expertise to assist NHMRC with the development and presentation of evidence based health advice and resources including: a. clinical practice, ethics and public health guidelines; b. systematic reviews and literature reviews; c. public statements; and d. information papers. NHMRC proposes to use the Panel to source providers to support the translation ofresearch into policy and practice according to NHMRC publications development criteria.
Funding: National Health & Medical Research Council ($10)
Scheme: Contract Research
Administered By: University of Tasmania
Research Team: Winzenberg TM; Makin JK; Palmer AJ; Shaw Kelly; Woodhouse P; Polles A
Year: 2018

Reducing the Burden of Liver Cancer for Tasmanians (2018)$350,000

Description: Hepatocellular carcinoma (HCC) is the most common form of primary liver cancer and is the third leading cause of cancer deaths internationally. It occurs most commonly amongst patients with cirrhosis of the liver, which is often caused by chronic infections with the hepatitis B and/or hepatitis C viruses. The clinical outcomes for patients diagnosed with HCC are highly dependent of the stage at which it is detected. Late detection is associated with significant morbidity and mortality. If detected early, HCC is potentially curable.Screening programs have been suggested to increase the rate of early diagnosis for at-risk groups. In Australia, current guidelines recommend HCC screening for all patients with cirrhosis, regardless of liver disease severity or aetiology. Screening consists of 6-monthly liver ultrasound and alpha-fetoprotein tests. Uptake of screening for HCC is very low in Australia, evidenced by the 5-year survival rate of just 17%. The aims of this project are to a) evaluate current uptake and adherence of HCC screening across Tasmania, b) develop strategies aimed at supporting at-risk patients to participate in regular HCC screening, c) evaluate the cost-effectiveness of screening interventions, and d) assess the effectiveness of new treatments for hepatitis C in reducing the rate of HCC in Tasmania.
Funding: Sefton Bottomley Liver Cancer Bequest ($350,000)
Scheme: Donation - Individual
Administered By: University of Tasmania
Research Team: de Graaff B; Palmer AJ; Yee KC; Cocker FM
Year: 2018

Health by Stealth: Increasing Physical Activity through Active Travel in Tasmania (2018 - 2020)$282,362

Description: We are facing a global inactivity crisis. Participation in recommended amounts of physical activity (PA) has remained stagnant since the 1980s,indicating limited population-level impact of strategies to promote PA. A shift in focus from leisure-time to transport-related PA holds promiseas an attractive but under-exploited opportunity to support individuals to incorporate more activity into daily life. Healthy transport options walking, cycling and public transport are critical social determinants of health, by reducing traffic accidents, increasing social contact,reducing air pollution, and increasing exercise. Improving our understanding of travel behaviours and identifying strategies to increase use ofhealthy transport options have been identified by our three highly engaged Tasmanian Partner Organisations as important priorities. This projectseeks to generate evidence with service providers, state government and local government authorities to support decision-making and resourceallocation in relation to increasing active and public transport use. Working closely with our Partners, we will analyse data from existing datasources to better understand Tasmanians travel behaviours and the factors that influence these, by evaluating the effectiveness of two realworldfiscal strategies aiming to increase active and public transport use, and by developing and implementing a knowledge transfer strategy toensure findings are effectively communicated. This project will generate some of the first evidence internationally about the effectiveness offiscal strategies to increase active and public transport use, and will provide crucial information to directly impact the work of service providers,decision makers, policy-makers and practitioners. By identifying effective strategies to increase PA through active transport, the implications of this project have the potential to make major direct health, social, environmental and economic impacts globally.
Funding: National Health & Medical Research Council ($272,362)
Scheme: Grant-Partnership Project
Administered By: University of Tasmania
Research Team: Cleland V; Ball K; Blizzard CL; Greaves S; Jose KA; Palmer AJ; Venn A
Period: 2018 - 2020
Grant Reference: 1152999

Ambulatory oxygen for interstitial lung disease (2018 - 2022)$1,503,717

Description: Exertional desaturation (low blood oxygen during exercise) is a hallmark of fILD, occurring in over 50% of patients. It is sometimes treated withambulatory oxygen therapy (AOT), which involves breathing supplemental oxygen during physical activity. However the absence of clinicaltrials has given rise to marked variations in policy and practice globally. Even where AOT is available, treatment adherence using the traditionaldelivery method of cylinder gas is extremely poor, as patient burden frequently outweighs any benefit. We have shown that (1) oxygen therapyimproves exercise capacity and markers of skeletal muscle metabolism, suggesting that AOT may impact on physical function, (2) AOT can bedelivered effectively in fILD using a portable oxygen concentrator (POC), which is lighter and more manoeuverable than a cylinder; and (3)POCs are acceptable to patients. We have recently modified a POC to deliver air, providing the effective sham treatment needed for a robustclinical trial.This multi-site randomised controlled trial will determine the clinical benefits and societal costs of AOT for people with fILD and exertionaldesaturation. Our hypotheses are that (1) AOT delivered using a POC will deliver clinically significant improvements in physical activity,symptoms and HRQoL; and (2) AOT delivered using a POC will be cost-effective from a societal perspective. We will conduct a randomisedcontrolled trial with blinding of participants, assessors and clinicians, and an embedded economic evaluation. 260 participants with fILD andexertional desaturation will be randomly assigned to use either AOT or air delivered using a POC for 6 months. If this trial demonstrates clinicaland economic benefits of AOT then the findings can be rapidly translated into practice, with global impact on ILD outcomes and costs.
Funding: National Health & Medical Research Council ($1,503,717)
Scheme: Grant-Project
Administered By: La Trobe University
Research Team: Holland A; McDonald C; Corte T; Chambers D; Palmer AJ; Ekstrom M; Glaspole I; Goh N; Hepworth G
Period: 2018 - 2022
Grant Reference: 1139953

The value of osteoporosis interventions evaluating the cost effectiveness and incorporating patients preference (2018 - 2021)$322,952

Description: The value of osteoporosis interventions: evaluating the cost-effectiveness and incorporating patients preference
Funding: National Health & Medical Research Council ($322,952)
Scheme: Fellowship-Early Career
Administered By: University of Tasmania
Research Team: Si L; Palmer AJ
Period: 2018 - 2021
Grant Reference: 1139826

Economic Impact of MS - 2007 cost of illness data AMSLS - PPMS sub-analysis (2017)$49,379

Description: Based on the published report Economic Impact of Multiple Sclerosis in 2010 Australian MS Longitudinal Study (AMSLS) Roche is interested in cost and utility data collected from patients with primary progressive multiple sclerosis (PPMS) only.Despite the type of MS not specifically being captured in the 2007 Cost Diary, 39 people with PPMS could be identified by matching participants with a more recent data collection.Roche is seeking Australian, PPMS-specific cost and utility data to inform a PBAC submission lodged in March 2017. A sub-analysis of the data presented in the 2010 report for PPMS patients only was identified as a viable data source to inform the PBAC submission. ObjectivePPMS-specific cost and utility data from the 2010 AMSLS analysis (2007 Cost Diary) categorised for applicability in a PBAC submission.Cost and utility data reported per EDSSResults available six weeks from the date of the fully signed contract.
Funding: Roche Products Pty Ltd ($49,379)
Scheme: Contract Research
Administered By: University of Tasmania
Research Team: van der Mei IAF; Palmer AJ; Taylor BVM
Year: 2017

Economic Impact of MS in Australia Report (2018) (2017 - 2018)$169,000

Description: Study to estimate the prevalence of MS in Australia;Data entry and data cleaning of 2016 AMSLS Cost Diaries;Analysis of the cost of illness data based on the AMSLS economic impact baseline surveys and cost diaries the analysis will include both direct and indirect costs of MS.An analysis of impact on utility/quality of life;Comparison of results with the 2005 and 2011 Economic Impact reports;Production of a final presentation Report to include:1.An overview of MS2.Prevalence of MS3.Healthcare costs and indirect costs (including lost productivity)4.Quality of life for those affected by MSProject to be conducted and completed with reference to and in accordance with the 2017 Economic Impact Report Terms of Reference and Merck Grant agreement with MS Research Australia
Funding: Multiple Sclerosis Research Australia ($169,000)
Scheme: Contract Research
Administered By: University of Tasmania
Research Team: van der Mei IAF; Palmer AJ; Taylor BVM
Period: 2017 - 2018

AusGo-SHEMO..Let's Go! Australian Gold Standard Health Economics Model of Osteoporosis (2017 - 2019)$393,987

Description: We will develop an unbiased, gold standard, validated, transparent health economics model of osteoporosis to identify cost-effective screeningand treatment strategies, and that will be made widely available to all stakeholders. Without this model, scarce health care resources may besquandered on osteoporosis screening strategies and osteoporosis-related fracture prevention medications that are not cost-effective. Worse,patient access to cost-effective medications may be delayed.
Funding: National Health & Medical Research Council ($393,987)
Scheme: Grant-Project
Administered By: University of Tasmania
Research Team: Palmer AJ; Eisman JA; Si L; Winzenberg TM; Sanders K; Center J
Period: 2017 - 2019
Grant Reference: 1127827

Centre of Research Excellence in Pulmonary Fibrosis (2017 - 2022)$2,498,606

Description: The Centre for Research excellence in Pulmonary Fibrosis (CRE-PF) aims to develop a sustainable nation-wide network, consisting of world recognized experts. The group will enable an integrative approach to solving PF through a layered strategy extending from molecules germane to disease pathogenesis, to human studies. With this approach the CRE-PF will set a new paradigm for synergy between academia, health care, health policy and the public, placing Australia at the forefront of innovation.
Funding: National Health & Medical Research Council ($2,498,606)
Scheme: Grant-Centre of Research Excellence
Administered By: University of Sydney
Research Team: Corte T; Knight D; Laurent GJ; Holland A; Chambers D; Moodley Y; Walters EH; Westall G; Glaspole I; Palmer AJ
Period: 2017 - 2022
Grant Reference: 1116371

Sustained Effective Oral Care to Significantly Reduce Aspiration Pneumonia experienced by Adults with Dementia in Residential Care (2016 - 2017)$99,572

Description: Oral care is critical to keeping the mouth clean and the body and brain as healthy as possible. This is especially the case for adults with dementia who rely on others for care. With poor oral health, harmful bacteria throughout the mouth cause tooth decay, gum inflammation, gum disease, and tooth loss. Frequently adults with dementia take multiple medications and the side-effects of these medications include reducing saliva and drying the mouth which in turn increase the harmful oral bacteria. When these harmful bacteria are breathed (or aspirated) into the lungs, the lungs become infected and aspiration pneumonia results. Adults with dementia, particularly those who live in residential communities, are vulnerable to aspiration pneumonia as they are often frail, not well nourished, have complicating medical conditions such as diabetes, heart disease, lung disease, and swallowing problems, as well as needing help from others for their care. We know, from published studies, that vulnerable adults who have their own teeth need to brush their teeth for 2 minutes after each meal. Adults who wear dentures need to clean their dentures each day and take them out when they are planning to sleep. Whether they have their own teeth or wear dentures, all adults with dementia also need to rinse their mouth after each meal. Unfortunately, oral care for adults with dementia in residential communities remains inconsistent and fragmentary. Our studies have documented the barriers, real and perceived, that prevent systematic oral care and we have developed a protocol to overcome these barriers. This protocol has five components: (1) establishment of an innovative Community of Practice (CoP) including health care professionals in the community-at-large, policy-makers, and consumers, together with visionary residential care leaders and nurse-carer champion partners to support staff and drive practice change; (2) education of nurse-carer champions by CoP members; (3) ongoing education and training of all point-of-care staff by nurse-carer champions as they work with RACF-based dental/oral health therapy students, and are supported by CoP members and online resources; (4) implementation of daily evidence-based oral care by staff; and (5) regular audits of daily oral care by nurse-carer champions and the students to ensure its sustained implementation.To measure the effectiveness of our protocol, we will follow 60 residents in each of two residential care communities in Tasmania. We will document the number of cases of aspiration pneumonia these residents experience before and after a 3-month period of daily evidence-based oral care (component 4 of the protocol). We also will document the number of times these residents have been transferred to hospital or admitted to hospital before and after the 3-month period of daily oral care. To document improvements in the residents oral, nutritional and general health and their quality-of-life (QOL), we will use the following measures that are appropriate for adults with dementia: (i) Oral Health Assessment Tool (OHAT), (ii) Mini-Nutritional Assessment (MNA), (iii) 3-day food record, (iv) Yale Swallow Protocol that identifies any signs of swallowing difficulty, (v) Sit-to-Stand Manoeuvre that identifies any difficulties with strength and movement, and (vi) the EuroQol-5 dimension tool that documents residents perceptions of their ability to move, care for themselves, and participate in daily activities along with any pain, discomfort or anxiety they are experiencing. We will administer these measures to the residents before and after the 3-month period of evidence-based daily oral care. We will analyse the data and write reports about the findings. We will publish these reports in academic journals and magazines that are widely-read by the public. We will network with social media outlets (radio, television, and Facebook sites) and policy-makers to share our findings as widely as possible. We antic
Funding: Dementia Collaborative Research Centre ($99,572)
Scheme: Grant-Project
Administered By: University of Tasmania
Research Team: Goldberg LR; Crocombe LA; Robinson AL; Lea EJ; Breen JL; Palmer AJ; McInerney F; Jones I; Beattie E; Toye C; Brennan DS; Heiss C
Period: 2016 - 2017

Comparison of learning focused cardiac ultrasound between self-directed/simulator and instructor/live model teaching (2016)$32,000

Description: Our proposed project aims to test whether our new self-directed learning simulator course is as effective as the current standard teaching model that uses lots of instructors and human volunteer models. The advantages of the simulator course include reduced reliance on instructors, increased availability of the course (ability to train a lot more doctors than the current standard course) to and the ability to also teach learning of diagnosis of heart disease (not possible with the current human model). A health economic analysis will also be performed to determine if the new simulator course is as cost-effective (economical) as versus the traditional course. If the new course is as effective and economical as the current course then the simulator course may become the new method for teaching bedside ultrasound as it has important advantages over the traditional method such as increased accessibility and capacity to train doctors, and the ability to teach how to diagnose heart conditions. This would result in significant health benefits to a very large number of patients worldwide.
Funding: Australian and New Zealand College of Anaesthetists ($32,000)
Scheme: Grant - Project Grant Funding
Administered By: University of Tasmania
Research Team: Canty DJ; Royse A; Royse C; Palmer AJ
Year: 2016

Does treating multiple sclerosis alter long-term disease outcomes? a natural history study (2016 - 2017)$180,000

Description: A natural history study of MS outcomes between a treated (Australian) versus untreated NZ population to study the long-term effects of MS disease modifying drugs. This is a clinical epidemiological project.
Funding: Multiple Sclerosis Research Australia ($180,000)
Scheme: Grant-Project
Administered By: University of Tasmania
Research Team: Taylor BVM; van der Mei IAF; Palmer AJ; Blizzard CL; Butzkueven H; Simpson Jr S; Kalincik T; Carroll W; Mason D
Period: 2016 - 2017

Evaluation of new Tasmanian general practice after hours incentive funding model and the value for money of GP Assist (2015 - 2016)$159,970

Description: This project will encompass an evaluation of the after-hours incentive funding model and the value-for-money of the GP Assist after-hours telephone support service. This research project will: a) conduct and survey of Residential Aged Care Facilities pre- and post- implementation of the new funding model and a survey of general practices post-implementation of the funding model; b) provide an analysis of existing data collections on clinic hours and MBF billings data; c) deliver a final report based on the evaluation of the collected data, providing recommendations on the feasibility and ongoing sustainability of the model.
Funding: Primary Health Tasmania ($159,970)
Scheme: Contract Research
Administered By: University of Tasmania
Research Team: Neil A; Nelson MR; Palmer AJ; Sanderson Kristy
Period: 2015 - 2016

GP Assist Evaluation (2015 - 2017)$41,335

Description: The University has been engaged by a third party Primary Health Tasmania to undertake collaborative research in relation to its funding of the GP Assist program and establishing whether it is adding value to the after-hours provision of general practice services to residential aged care facilities, palliative care services and the Tasmanian community (Third Party Services). The Crown is engaging the University under this Agreement to conduct additional research as part of the University undertaking the Third Party Services to determine whether the Crowns funding of GP Assist to further assess the GP Assists contribution (if any) to the efficiency and sustainability of the rural health services.
Funding: Department of Health and Human Services Tasmania ($31,335); Tasmanian Health Service - Southern Region ($10,000)
Scheme: Contract Research
Administered By: University of Tasmania
Research Team: Neil A; Nelson MR; Palmer AJ; Sanderson Kristy
Period: 2015 - 2017

DEVA MS: DEvelopment and VAlidation of a cost effectiveness simulation model for Multiple Sclerosis and implications for health policy (2015 - 2016)$160,000

Description: The number of people with multiple sclerosis (MS) is increasing dramatically in Australia, with rapidly escalating associated costs, both direct due to medical expenses and indirect due to lost or reduced employment. Existing and upcoming treatments for MS are expensive, with current prices of up to $25,000 per patient per year and rising. Using the best available data, this study will identify the treatments that are greatest value for money for the most common form of MS (relapsing-remitting MS), with a goal to reduce wastage of limited healthcare resources.
Funding: Multiple Sclerosis Research Australia ($160,000)
Scheme: Grant-Project
Administered By: University of Tasmania
Research Team: Palmer AJ; Taylor BVM; van der Mei IAF; Clarke Philip; Simpson Jr S
Period: 2015 - 2016

Provision of Health Economics consultancy service to develop a new Tasmanian GP After Hours Incentive Funding Model(s) (2014)$79,822

Description: This project will develop a series of increasingly redistributive funding models supporting the provision of accessible and effective after hours care throughout Tasmanian that address core objectives and identified areas of concern.
Funding: Primary Health Tasmania ($79,822)
Scheme: Contract Research
Administered By: University of Tasmania
Research Team: Neil A; Palmer AJ; Nelson MR
Year: 2014

Dementia-related presentations at the Royal Hobart Hospital - A pilot program for redesigning state-wide clinical care pathways involving Tasmanian residential aged care facilities (RACFs) and their c (2014)$6,873

Description: This project explores dementia-related presentations to the RHH to inform the development of new clinical pathways to reduce preventable and unplanned hospital transfers that are costly and have poor outcomes for people with dementia. Care pathways from RACFs and community settings to the RHH will be reviewed.
Funding: Royal Hobart Hospital Research Foundation ($6,873)
Scheme: Grant-Starter
Administered By: University of Tasmania
Research Team: Annear MJ; Nicols H; Powell D; Bell EJ; Elliott KJ; Palmer AJ; Vickers JC; Eccleston CEA; McInerney F
Year: 2014

Clinical Redesign of respiratory pathways in residential aged care (2014)$80,000

Description: Respiratory conditions are a leading cause of unplanned admissions from residential aged care and the wider community. This project aims to reduce the burden of preventable unplanned admissions from aged care facilities and improve health outcomes.
Funding: University of Tasmania ($80,000)
Scheme: vTAHSP Demonstration Projects
Administered By: University of Tasmania
Research Team: Bell EJ; Robinson AL; Walters EH; Palmer AJ; Winter RE; Annear MJ; Elliott KJ
Year: 2014

Improving prevention and early intervention for type 2 diabetes in Tasmania (2014)$54,673

Description: This project will use the AUSDRISK tool in a random mail-out to seniors card holders and via clinical contact at Clarence ICC (to increase the numbers of adults assessed in healthcare settings). Training will be provided for optomeyes and Clarence ICC personnel in the use of the tool. Follow up will be conducted with respondents who scored as being high risk, including recommended management by both the individual and their GP.
Funding: University of Tasmania ($54,673)
Scheme: vTAHSP Demonstration Projects
Administered By: University of Tasmania
Research Team: Macintyre K; Burgess JR; Palmer AJ; Shaw K; Bingham L
Year: 2014

Bariatric surgery in Tasmania: investigating health service use, costs, patient outcomes and policy options (2014 - 2019)$839,027

Description: About 1 in 20 Tasmanians are severely obese. Bariatric surgery can improve health for individuals with severe obesity but access to surgery is poor for most public patients. This study will investigate the pathways of patients referred for bariatric surgery in the Tasmanian public and private hospital systems to better understand the demand for surgery, the health outcomes, and costs associated with these different pathways. The findings will inform public policy and resource allocation.
Funding: National Health & Medical Research Council ($644,027)
Collaborators: Department of Health and Human Services Tasmania ($150,000); Department of Premier and Cabinet ($45,000)
Scheme: Grant-Partnership Project
Administered By: University of Tasmania
Research Team: Venn A; Palmer AJ; Ezzy D; Blizzard CL; Nelson MR; Neil A
Period: 2014 - 2019
Grant Reference: 1076899

Bariatric surgery in Tasmanian public hospitals: investigating health service use, costs, and policy options (2014)$8,088

Description: Bariatric surgery is considered an effective treatment for significant obesity-related illness but it is difficult to access in Australian public hospitals. By describing Tasmanian public patients' characteristics, clinical pathways, costs and outcomes this project will support better informed decision-making about Tasmanian public hospital services for clinically obese patients.
Funding: Royal Hobart Hospital Research Foundation ($8,088)
Scheme: Grant-Starter
Administered By: University of Tasmania
Research Team: Venn A; Wilkinson Stephen; Greenaway T; Hensher M; Palmer AJ; Blizzard CL; Neil A
Year: 2014

Guidance of Heart Failure Management Programs by Risk Assessment (2013 - 2018)$1,422,739

Description: The aims of this project are to reduce Heart Failure (HF) admissions and costs in Tasmania by: i) using data linkage to identify locations where community service delivery should be targeted, and to evaluate current performance in HF readmission across the State; ii) developing a risk algorithm for HF readmission, including psychosocial determinants; iii) using i) and ii) devising a novel means of providing a disease management program (DMP), titrated to risk assessment, with physiologic assessment used to guide the management of the highest risk patients; iv) developing a clinical trial to define the merits of this approach; v) evaluating the cost-effectiveness of this intervention; vi) presentation of educational activities with community-based providers. A successful intervention is likely to be sustainable. As HF readmissions in Tasmania cost ~4550 bed days/y, the investment in this grant (~$1/2m/y) could be reproduced by a 50% reduction of readmissions.
Funding: National Health & Medical Research Council ($942,739)
Scheme: Grant-Partnership Project
Administered By: University of Tasmania
Research Team: Marwick TH; Venn A; Sanderson Kristy; Nelson MR; Palmer AJ; Blizzard CL
Period: 2013 - 2018
Grant Reference: 1059738

Improving care through imbedding general practitioners within residential aged care facilities (2013 - 2015)$404,875

Funding: Bupa Foundation (Australia) Limited ($404,875)
Scheme: Grant-Expression of Interest Grants Program
Administered By: University of Tasmania
Research Team: Robinson AL; Haines Terry; Palmer AJ; Vickers JC
Period: 2013 - 2015

Development and validation of a health policy simulation model for type 1 diabetes (2012 - 2014)$336,549

Funding: National Health & Medical Research Council ($336,549)
Scheme: Grant-Project
Administered By: University of Melbourne
Research Team: Clarke Philip; Palmer AJ; Milne George; Briggs Andrew; Herman W; Eliasson B
Period: 2012 - 2014
Grant Reference: 1028335

Epidemiology and economic impact of injuries to jockeys in the thoroughbred racing industry (2011 - 2012)$50,855

Funding: WorkCover Tasmania ($50,855)
Scheme: Grant
Administered By: University of Tasmania
Research Team: Palmer AJ; Hitchens PL
Period: 2011 - 2012

5th Mount Hood Challenge Conference Malmo Sweden 18-19 Sept 2011 (2010)$14,018

Funding: Janssen-Cilag Pty Ltd ($14,018)
Scheme: Consultancy
Administered By: University of Tasmania
Research Team: Palmer AJ
Year: 2010

Improving health and wellbeing in the Tasmanian State Service workforce (2010 - 2014)$916,250

Funding: National Health & Medical Research Council ($856,250)
Scheme: Grant-Partnership Project
Administered By: University of Tasmania
Research Team: Venn A; Sanderson Kristy; Blizzard CL; Taylor Roscoe; Wood-Baker R; Palmer AJ; Nelson MR; Turner P
Period: 2010 - 2014
Grant Reference: 544954

Research Supervision

Current

Completed

Current

Degree	Title	Commenced
PhD	Public Bariatric Surgery in Tasmania: Patient pathways and health service use	2014
PhD	Health Economics of Obesity in Adult Population in Ghana	2017
PhD	Health-Economic Consequences of Multiple Sclerosis in Australia	2017
PhD	Understanding the Prevalence and Impact of Comorbidities on People with Multiple Sclerosis	2017
PhD	Improving the Lives of People with Multiple Sclerosis	2017
PhD	Cost-Effectiveness of Formal and Informal Prevention and Treatment Against Upper Respiratory Tract Infections Among Rural Residents in Anhui, China	2017
PhD	Health Economics in Bariatric Surgery	2017
PhD	Assessment Framework for the Evaluation of Wildfire Risk Reduction Strategies	2018
PhD	Assessing the Burden and Economic Impact of IPF in Australia	2018
Masters	Understanding Primary Liver Cancer in Tasmania	2018
PhD	Health Economic Aspects of Primary Cancers of the Liver	2018
PhD	Using Data Linkage to Estimate the Burden of Illness of Chronic Diseases in Tasmania: The examples of chronic drug abuse and diabetes	2019

Completed

Degree	Title	Completed
PhD	The Health Economics of Obesity and Bariatric Surgery Candidate: Julie Anne Campbell	2018
PhD	The Health and Economic Burden of Multimorbidity in Australia Candidate: Lili Wang	2017
PhD	Bariatric surgery: Pathways, perspectives and policy options Candidate: Melanie Jayne Sharman	2017
PhD	The Health Economics of Haemochromatosis Candidate: Barbara de Graaff	2016
PhD	Health Economics in Osteoporosis: Construction and application of a new state-transition microsimulation model Candidate: Lei Si	2016
PhD	Healthy, wealthy and wise. Investigating the application of health economics in workplace health promotion: the economic evaluation of Healthy@Work Candidate: Siyan Baxter	2015